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SYNOPSIS 
 
 
Oxidative stress is a common issue in neurodegenerative diseases such as 
Parkinson´s disease (PD), Alzheimer´s disease (AD), amyotrophic lateral 
sclerosis (ALS), Huntington´s disease (HD), and fronto-temporal dementia 
(FTD). Oxidative stress occurs when the cellular redox balance is impaired 
leading to excessive production of reactive oxygen and nitrogen species 
(ROS/RNS). ROS/RNS and oxidative modified molecules accumulate in the 
cells over the time and contribute to cellular senescence and to the aging process. 
Since most neurodegenerative diseases are late-onset it is likely that oxidative 
stress-mediated damage accumulation occurring over the time contribute in the 
onset of the pathology. However, numerous evidences of oxidative stress-
mediated damage have been found in developmental brain diseases, such as Rett 
Syndrome (RTT), in which there is not aging contribution. Rett Syndrome is an 
X-linked pathology mainly caused by the loss of function (LoF) mutations in the 
gene encoding Methyl CpG binding Protein 2 (MeCP2). Despite the studies done 
so far, the molecular mechanisms that link MeCP2 loss of function to the 
pathology outcome are still not fully understood. Oxidative stress is looked at as 
a possible actor involved in the disease. High level of oxidatively modified 
proteins and lipids and altered expression of genes involved in both oxidative 
stress defense and mitochondrial activity have been observed in RTT patients. 
Moreover, MeCP2 reactivation in mouse models not only attenuates neural 
dysfunction but also restores the redox homeostasis. However, the molecular 
pathways that link the absence of MeCP2 protein to oxidative stress state in the 
pathophysiology of this brain disease are still unknown.  
I investigated the role of oxidative stress in Rett syndrome, taking advantage 
from a mouse embryonic stem (mES) cell line carrying a deletion of MeCP2 gene 
(MeCP2-/Y mES). In particular, I analyzed the effect of oxidative stress, induced 
via treatment with the enzyme Glucose oxidase (GOX) that produces H2O2 in the 
culture medium, on WT and MeCP2-/Y mES derived neurons. I studied the 
mitogen-activated protein kinase (MAPK) cellular response pathways and the 
apoptotic activation in mES derived neurons upon oxidative stress stimulation. I 
observed that MeCP2-/Y mES derived neurons resided in an active cellular 
response state and that the response rate increased upon treatment with GOX. 
Moreover, GOX treated MeCP2-/Y neurons did not die via apoptosis as shown 
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by the lack of activation of caspase 3 protein and the high level of the anti-
apoptotic Bcl2 protein. Interestingly, MeCP2 protein level increased in GOX 
treated WT mES derived neurons compared to untreated condition thus giving 
strength to the possible role of MeCP2 protein in the regulation of cellular 
response against oxidative stress.  
So far, studies on Rett Syndrome, as well as other brain diseases, have been 
carried out using mainly rodent animal models. However, it is important to take 
into account the differences that exist between humans and rodents. During the 
very last years, new strategies to model and study human brain diseases have 
been emerging. Relying on the use of human embryonic or induced pluripotent 
stem cells, it is possible to generate complex three-dimensional (3D) structures, 
the so-called cerebral organoids (Minibrain/MB). The use of human specific stem 
cells allows following the species-specific differentiation patterning and the 
presence of multiple human brain-like structures allows studying the interactions 
between several areas of the brain in an in vitro model system that resembles 
human brain development and architecture. 
I was fascinated by the possibility to use MBs to analyze the role of oxidative 
stress in neurological disease. To this aim, I joined the lab directed by Prof. Dr. 
Peter Heutink at the German Center for Neurodegenerative Diseases (DZNE) in 
Tübingen where I experienced the methodology to generate cerebral organoids 
in order to evaluate their possible use to model brain developmental and 
neurodegenerative diseases. In particular, I sought to establish a 3D model for 
Parkinson’s disease (PD). PD is the most common neurodegenerative disease 
with motor symptoms. This complex multifaceted disease has long been believed 
to be only environmental. However, the recent genome wide association studies 
(GWAS) on PD patients have identified hundreds of genetic risk factors and 
many of them are involved in mitochondrial function and/or oxidative stress 
related. Alpha-synuclein (SNCA) gene is the most common genetic risk factor 
associated with both familiar and sporadic forms of PD. The alpha-synuclein (-
syn) protein function is still unclear, but it is known that mutations of -syn 
proteins lead to aggregates formation in dopaminergic neurons (Lewy bodies and 
Lewy neurites) that cause toxicity in the cells. The molecular mechanisms that 
lead to -syn aggregation and toxicity are not fully defined. I aimed to establish 
3D Minibrains using lentiviral-transduced induced pluripotent stem (iPS) cells 
overexpressing SNCA in order to study the molecular mechanisms leading to -
syn aggregation and toxicity. I reproduced a previously established 3D MB 
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differentiation protocol and characterized MBs growth and differentiation up to 
three months in culture. 3D MBs acquired a good degree of neural maturation 
starting from two months in culture and retained the human cell identity 
specification. Indeed, differentiated neurons showed a spatial patterning similar 
to that observed in the in vivo developing human brain. However, the MB 
generation was highly variable between and within the experiments and this 
highlighted the necessity to make MB generation more reproducible. I tested the 
effect of SMAD inhibitors, to modulate the TGF-beta and BMP signaling 
pathways responsible for cell differentiation. SMAD inhibitors are known to 
repress cell differentiation towards mesoderm and endoderm lineages and they 
have already been successfully used in two-dimensional (2D) iPS neural 
differentiation protocols. The SMAD inhibitors treatment reduced significantly 
the expression of early mesodermal (BRACHYURY) and endodermal (GATA4) 
genes and increased the expression of neural precursor genes (OTX1 and PAX6) 
in one-month old MBs. Nevertheless, this treatment did not significantly improve 
the mature neuron genes expression at any of the time points analyzed. 
Interestingly, mature neuron genes were less expressed in MBs overexpressing 
SNCA compared to WT, suggesting an impairment of differentiation in SNCA 
overexpressing MBs that might occur in the late stages of differentiation. 
Moreover, I observed that three-months old SNCA overexpressing MBs 
exhibited higher level of heme oxygenase 1 (HMOX1) mRNA compared to age-
matched WT MBs. In line with previous studies, these results suggested the 
enhanced activation of nuclear factor E2-related factor 2 (Nrf2) signaling 
pathway in response to SNCA overexpression. Therefore, these results showed 
that MBs are an interesting tool to study some aspects of neurodegenerative 
diseases, such as the link between -syn protein aggregation and oxidative stress 
response in late onset Parkinson´s disease.  
The generation of 3D organoid cultures opened the way to a new human-
specific model system for brain research that compensates the limitations derived 
from both animal models and 2D in vitro systems. In this perspective, MBs might 
be incredibly useful to model Rett Syndrome and to test possible therapeutic 
strategies in a complex human-specific model system.  
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Chapter 1 
 
OXIDATIVE STRESS 
 
 
 
1.1  General overview on Oxidative stress biochemistry 
 
Oxidative stress (OS) is defined as the cytotoxic condition in which the 
biochemical processes leading to the production of reactive oxygen and nitrogen 
species (ROS/RNS) overcome those responsible for their removal, the so-called 
antioxidant cascade (Sayre et al., 2008). ROS production arises from the 
formation of the anion superoxide (O2-), mainly generated by the reaction of the 
molecular oxygen with electrons leaked from the mitochondrial electron 
transport chain (Fridovich, 1978). Anion superoxide is not the most dangerous 
component, but the precursor of other reactive intermediates that are produced 
along the consecutive univalent reduction reactions of molecular oxygen to 
water. These intermediates are superoxide (HO2), hydrogen peroxide (H2O2), and 
the hydroxyl radical (HO-) (Imlay et al., 1988). The hydroxyl radical is 
considered the most reactive specie and the main instigator of oxidative stress 
damage (Sayre et al., 2008). This is rapidly generated by the decomposition of 
H2O2 to HO- in the presence of Fe2+ by the Fenton reaction. Accumulating levels 
of superoxide can also react with the diffusible nitric oxide (NO) and generate 
peroxynitrite (ONOO−) and related RNS. These RNS are capable of both 
oxidation and nitration chemistries, that result in a condition known as 
“nitrosative stress” (Alvarez and Radi, 2003). 
Aerobic organisms have developed several systems to counteract the 
dangerous action of ROS and RNS and these include both enzymatic and non-
enzymatic antioxidants. About the enzymatic antioxidant cascade, the first 
enzymes involved are the superoxide dismutases (SOD) that catalyze superoxide 
dismutation to hydrogen peroxide and oxygen (Fridovich et al., 1978). 
Subsequently, hydrogen peroxide is reduced by the catalase (CAT) and 
peroxidase (PrDx) enzymes to form H2O and O2 (Evans, 1907; Fridovich et al., 
1978). The non-enzymatic molecules capable of the reduction of oxidant species 
include the hydrophilic glutathione (GSH) and ascorbic acid (vitamin C), or -
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tocopherol (vitamin E), hydrophobic, that is concentrated in the membranes 
(Coyle and Puttfarcken, 1993).   
In physiological conditions, ROS are produced as byproducts of normal 
metabolic processes, such as mitochondrial phopshorylative oxidation, and they 
play a regulatory role as second messengers in cellular processes via activation 
of various enzymatic cascades and several transcriptional factors (Droge, 2002). 
However, ROS and RNS are highly reactive molecules and in oxidative 
stress conditions they can react and damage unconditionally proteins, nucleic 
acids and lipids (Fig. 1.1; Frijhoff et al., 2015). Proteins and amino acids are the 
most affected molecules by the action of ROS and RNS and the damage can occur 
both at backbone and side chain sites. Oxidation of protein results in cross-
linking, backbone fragmentation and side-chain cleavage (Stadtman, 2006). 
Reaction of ROS and RNS with amino acids, especially the sulfur-containing 
cysteine (Cys) and methionine (Met), leads to the formation of carbon-centered 
or nitrogen-centered radicals, hydroperoxide and carbonyl groups and, in minor 
amounts, of nitrosated products (Alvarez and Radi, 2003; Davies, 2005). 
Oxidation of Met to methionine-sulfoxide (MetO) is rescued by the action of 
specific methionine-sulfoxide reductases that promote the thioredoxin-dependent 
reduction of MetO back to Met (Stadtman, 2006). Thus, this cyclic oxido-
reduction of Met serves as a buffering mechanism to increase the resistance to 
oxidative damage. Oxidation of nucleic acids results in strand breaks and base 
modifications (Imlay et al., 1988; Aruoma at al., 1989; Honda et al., 2005; 
Nunomura et al., 2012). RNA molecules rather than DNA are more susceptible 
to oxidative stress because of their single-stranded structure and the absence of 
protective histones (Nunomura et al., 2012). The hallmark of RNA oxidation is 
the formation, iron-dependent, of 8-hydroxyguanosine (8-OHG) (Nunomura et 
al., 2012). ROS can also promote lipid peroxidation that, beside the cellular 
membrane disruption, generates other toxic products such as aldehydes, which 
include malonic dialdehyde (MDA) and 4-hydroxyalkenals, in particular 4-
hydroxynonenal (4-HNE) and 4-hydroxyhexenal (Comporti, 1989; Esterbauer et 
al., 1991). All of these are highly reactive aldehydes that can react and modify 
thiol groups and amino acids and exert mutagenic and toxic effects in cells and 
tissues (Esterbauer et al., 1991).  
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Fig. 1.1 Schematic representation of the ways of production of ROS and RNS and main 
effect on biological macromolecules (source from Sayre et al., 2008). 
 
The amounts of ROS and, in turn, of the oxidatively modified 
macromolecules increase with age in various tissues due to metabolic or 
pathophysiologic changes and environmental stress exposure (Zhang et al., 
2015). Moreover, it has been hypothesized that such accumulation of oxidative 
damage might be a former cause of aging and cellular senescence and of wide 
variety of diseases such as cancer, arthritis, autoimmune disorders, 
cardiovascular and neurological diseases (Harman, 1956; Harman, 1981; Rebrin 
et al., 2003; Stadtman, 2006) 
 
 
1.2  Cellular response to oxidative stress  
 
1.2.1 Cellular response to oxidative stress: Activated molecular 
pathways  
 
The treatment with oxidant agents stimulates the activation of mitogen 
activated protein kinase (MAPK) superfamily in the cells in a dose-dependent 
manner (Usatyuk et al., 2003). MAPKs constitute a signal transduction pathway 
well-known to exert a major role in regulating cell response to a multitude of 
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external stimuli. Three main families belong to MAPK superfamily: the 
extracellular signal-regulated protein kinases (Erk 1/2s), the c-Jun N-terminal 
kinases or stress-activated protein kinases (JNKs) and p38 kinase family (Cowan 
et al., 2003). MAPKs are the last actors of the signal transduction cascades that 
activated, via phosphorylation, in response to specific class of external stimuli. 
Erk 1/2 proteins are activated by mitogens and growth factors, while JNK and 
p38 proteins are mainly active upon inflammatory cytokines and various physical 
and chemical stressors stimulation (Raingeaud et al., 1995; Hibi et al., 1993; 
Sluss et al., 1994; Usatyuk et al., 2003). The stimulus specific activation of 
MAPKs culminates with the phosphorylation, and hence the activation of the 
target proteins, mainly nuclear protein such as transcription factors responsible 
for gene expression regulation (Fig. 1.2; Cowan et al., 2003). As the stimulation 
of MAPKs differs among each other also the cellular responses are different. 
Erk1/2 downstream effectors are mainly involved in cell proliferation, 
differentiation and survival, while JNK and p38 MAPKs targets regulate 
inflammatory response, and osmoregulation respectively and both regulate 
apoptosis (Cowan et al., 2003).  
Important to note, all the MAPKs have been associated with regulation of 
autophagy (Sridharan et al., 2011). While Erk 1/2 and JNK MAPKs have been 
positively associated with induction of autophagy, p38 contribution is 
controversial, although its activation seems to inhibit autophagy (Sridharan et al., 
2011; Zhang et al., 2015).  
Autophagy is usually referred to as a survival mechanism activated in either 
starvation or stress conditions even though has also been suggested as another 
cell death pathway (Klionsky et al., 2000; Li et al., 2017). Cells activate 
autophagy to counteract nutrient deprivation via self-component organelles 
digestion to recycle the basal molecules needed to sustain very essential 
metabolic pathways. In case of prolonged starvation, active autophagy can trigger 
apoptosis or necrosis, thus contributing to cell death. Another study suggested 
that the Erk 1/2-mediated autophagic activation might be one of the causes of 
neurodegeneration in an MPP+-induced in vitro model for PD (Chu et al., 2007). 
Defective autophagy has been reported in RTT derived primary skin fibroblasts 
(Sbardella et al., 2017). In particular, the authors showed the inability of RTT 
fibroblasts to activate autophagy upon starvation (Sbardella et al., 2017). 
Although, autophagy might contribute differently in fibroblasts than in post-
mitotic neural cells (Tsujimoto and Shimizu, 2005). Post-mitotic neurons, 
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indeed, lose their proliferation potential. Therefore, autophagy might be 
extremely important as a survival pathway in post-mitotic neurons upon stress 
and injuries.  
 
 
Fig. 1.2 MAPKs activation pathways (source from Cowan et al., 2003). 
 
However, Erk 1/2 is also known to promote cell survival by regulation of the 
Bcl2 family.  
Moreover, p38 and AMPK have been reported to regulate Nrf2/ARE-
mediated response to oxidative stress induced by oxidants such as 4-HNE 
(Zimmermann et al., 2015; Ma et al., 2015; Wu et al., 2015). 
The Nrf2 signaling pathway is maybe the most important in defense against 
oxidative stress (Zhang et al., 2015) and Nrf2 is thought to be the master regulator 
of redox homeostasis in the cells. Nrf2 is a transcription factor that binds to the 
antioxidant response element (ARE), also referred to as electrophile response 
elements (EpRE) (Moi et al., 1994) and regulates the expression of antioxidant 
genes. Under physiological condition, Nrf2 is sequestered in the cytoplasm by 
interaction with the Kelch-like erythroid cell-derived protein with CNC 
homology-associated protein 1, (Keap1), also referred to as inhibitor of Nrf2 
(INrf2). Through the Kelch-domain, Keap1 protein sequester Nrf2 in the 
cytoplasm where it is constantly degraded by the ubiquitin proteasome 
machinery. Upon stimulation by oxidants or electrophiles, Keap1 loses its 
12 
 
capacity to bind Nrf2 that is released and able to translocate into the nucleus 
where it heterodimerizes with other proteins, such as Mafs, c-Jun, and ATF4, and 
binds to the ARE in the DNA (Zhang et al., 2015).  
The binding of Nrf2 to ARE controls the expression of hundreds of 
antioxidant genes including -glutamylcysteine synthetase (GCS; Moinova et al., 
1998), heme oxygenase 1 (HMOX-1), peroxidoredoxin (Ishii et al., 2000) 
superoxide dismutase family proteins, catalase, glucose-6-phosphate 
dehydrogenase (G6PDH) and NAD(P)H:quinoneoxidodreductase (NQO-1). 
Beside the oxidants and electrophiles, also phosphorylation might play a role in 
regulation of Nrf2/ARE-mediated antioxidant response. Protein kinase C (PKC)-
mediated phosphorylation at Ser 40 of Nrf2 has been shown to be important for 
its release from Keap1, even though is dispensable for Nrf2 stabilization and 
nuclear translocation (Huang et al., 2002; Bloom and Jaiswal, 2003). 
Noteworthy, the cytotoxic effect of oxidants follows a dose-dependent 
mechanism. For example, at physiological level, 4-HNE stimulates cell survival 
through activation of Nrf2-ARE, NFkB and MAPK pathways and promotion of 
cell proliferation and autophagy. Higher 4-HNE concentration, instead, induces 
proliferation arrest and induction of apoptosis. The threshold that distinguishes 
between physiological or cytotoxic condition depend on the cell type, DNA 
repair capacity or cellular metabolic circumstances (Ayala et al., 2014). 
 
 
1.2.2 Cellular response to oxidative stress: Programmed cell 
death  
 
Apoptotic cell death 
Since oxidative stress is a matter of equilibrium, both ROS and oxidatively 
modified macromolecules play a dual role in the cells. At low physiological, or 
under-toxic, levels ROS can stimulate a pro survival response. As the ROS 
concentration and the cellular damage increase the cellular response can switch 
from a pro-survival to a cell death program such as apoptosis or necrosis (Elmore, 
2007). Apoptosis refers to a tightly-regulated energy-dependent mechanism of 
cell death that involves various molecular pathways. Apoptosis occurs as a 
normal process during development and aging and cellular turnover in tissues as 
well as a defense mechanism against toxins or stressors and during immune 
response (Elmore, 2007). Apoptotic cells are characterized by shrinkage and 
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exhibit several biochemical modifications such as protein cross-linking and 
cleavage, DNA fragmentation, membrane loosing and phosphatidylserine (PS) 
exposure. PS exposure to the outside face of membrane cells is recognized by 
phagocytic cells that get rid of dead cells and cell debris. 
There are three main apoptotic pathways: the extrinsic or death receptor 
pathway, the intrinsic or mitochondrial pathway and the perforin-granzyme 
dependent pathway (Fig. 1.3; Elmore, 2007). All the three pathways involve the 
group of cysteine proteases, known as caspases, which activate upon stimulation 
via autocatalytic cleavage.  
The extrinsic and perforin/granzyme pathways are mediated by cytotoxic T 
lymphocytes (CTL) to kill specifically virus-infected or transformed cells. The 
extrinsic pathway is initiated by activation of death-receptors such as Fas receptor 
(FasR) or tumor necrosis factor (TNF) receptor and as consequence lead to the 
formation of the death-inducing signaling complex (DISC). This, in turn, 
stimulates the auto-catalytic activity of procaspase 8. Active caspase 8 triggers 
the execution phase via activation of procaspase 3.  
 
Fig. 1.3 Representation of the three apoptotic pathways. The three apoptotic pathways are 
activated upon different stimulations but converge in the activation of the same execution 
pathway (source from Elmore, 2007).  
 
Perforins, a class of pore forming proteins, and granzymes, a class of serine 
proteases, are secreted by CTL via exocytosis and subsequently uptaken by the 
14 
 
target cells. Granzymes A and B are the main responsible for apoptotic induction 
and, in particular, they induce cell death via caspase-independent and caspase-
dependent mechanisms respectively. Granzyme B activates by cleavage 
procaspase 10 which, in turn, activates procaspase 3, or else directly activates 
procaspase 3. Granzyme A, instead, disrupts by cleavage the complex responsible 
for DNA protection and repair (SET complex) and induces DNA degradation via 
DNase activation (Elmore, 2007). 
The intrinsic pathway activated by a wide range of stimuli that include 
starvation, radiations, toxins and oxidative stress and it is usually triggered by 
mitochondria that act as sensors of cellular health. All of these stimuli result in 
change of mitochondrial membrane permeability, opening of the mitochondrial 
permeability transition (MPT) pore, and release of cytochrome c and 
Smac/DIABLO protein groups from the intermembrane space into the cytosol. 
These, in turn, trigger the activation of procaspase 3 (Elmore, 2007). The intrinsic 
pathway is regulated by the members of the Bcl2 family of proteins (Cory and 
Adams, 2002) which include both pro-apoptotic (Bcl-10, Bax, Bak, Bid, Bad, 
Bim, Bik, Blk, Puma and Noxa) and anti-apoptotic (Bcl2, Bcl-x, Bcl-XL, Bcl-
XS, Bcl-w, BAG) proteins. These proteins are mainly involved in the regulation 
of cytochrome c release from the mitochondria. Bcl2 inhibits cytochrome c 
release in the cytoplasmic space via inhibition of Bax. Upon stimulation, Puma 
and Noxa localize to the mitochondria and interact with anti-apoptotic Bcl2. 
Inhibition of Bcl2 allows the release of cytochrome c and, in turn, the activation 
of caspases 9 and 3 (Oda et al., 2000). 
Both intrinsic and extrinsic apoptotic pathways culminate in the execution 
pathway with the activation of procaspase 3. Activated cleaved caspase 3 triggers 
proteases which, in turn, cleave their respective substrates such as cytoskeleton 
or DNA repair proteins (i.e. PARP) and nucleases responsible for DNA 
fragmentation thus leading to cellular degradation.  
Noxious agents might also lead to necrotic death. In contrast to apoptosis, 
necrosis does not involve tight-regulated molecular pathways and is usually 
accompanied by inflammation. 
 
Autophagic cell death 
Whether or not autophagy is a cell death mechanism is still under debate 
since it is unclear if the activated autophagy observed in dying cells is the cause 
of cell death either the last effort of a survival mechanism (Tsujimoto and 
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Shimiyu, 2005; Liu and Levine, 2015). Autophagy is activated by starvation, as 
well as hypoxic or toxic conditions and high temperature, to counteract nutrient 
deprivation and to get rid of damaged organelles and cellular components. The 
molecular machinery is regulated by the autophagy-related gene (Atg) protein 
family, identified in yeasts, and the autophagic process has been conserved 
during evolution (Fig. 1.4). Autophagy starts with the formation of a double 
membrane structure (vesicle nucleation) promoted by phosphatidylinositol 3 
(PI3) kinase class 3 complex, which include Atg6. The double membrane 
elongates to form a vesicle, the so-called autophagosome, which include the 
cytoplasmic material to digest. Autophagosome elongation and completion are 
carried out by two ubiquitin-like conjugation systems: the Atg12 and LC3 
conjugation systems.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.4 Representation of the autophagic pathway (source from Liu and Levine, 2015) 
 
Finally, the autophagosome fuses with lysosome to form the 
autophagolysosome. The lytic enzymes contained in the autophagolysosome are 
responsible for the degradation of the sequestered cytoplasmic material (Fig. 1.4; 
Liu and Levine, 2015).  
Autophagic cell death has been proposed after the observation that the 
inhibition of autophagosome formation suppresses cell death induced by some 
specific cytotoxic agents in apoptotic deficient mouse and human cellular 
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systems (Shimizu et al., 2004; Yu et al., 2004). Moreover, the observation that 
autophagic cell death is triggered by Bcl2 family members in this model systems, 
let the authors hypothesize that mitochondria might be involved in regulation of 
autophagic cell death (Shimizu et al., 2004). The balance between pro-survival 
autophagy and autophagic cell death might rely on the regulation of Atg protein 
genes (Shimizu et al., 2004). Moreover, JNK activation has been suggested as 
another possible mediator that triggers autophagic cell death (Yu et al., 2004). 
However, the involvement of Atg members as well as JNK in other cell death 
mechanisms, such as apoptosis, makes challenging the statement of the existence 
of autophagic cell death, which remains controversial. 
 
 
1.3 Oxidative stress and neurodegeneration  
 
The central nervous system (CNS) is the most susceptible organ to oxidative 
stress given the relatively low levels of antioxidants (i.e. GSH) and the high 
content of oxidable molecules such as catecholamines and polyunsaturated fatty 
acids (PUFA; Sayre et al., 2008). The brain alone consumes approximately 20% 
of the total energy supply of the body, including oxygen. 
The bioenergetics of neural cells mostly relies on pentose phosphate pathway 
(PPP) for glucose metabolism (Herrero-Mendez et al., 2009; Rodriguez-
Rodriguez et al., 2013). This represents an important route for neuronal cells to 
counteract the susceptibility to oxidative stress. Indeed, PPP is essential to sustain 
glutathione buffering via production of reduced NADPH during the first rate-
limiting reaction catalyzed by Glucose-6-Phosphate Dehydrogenase (G6PD). 
Beside the redox balancing, PPP in neurons is also essential to reduce the 
mitochondrial mediated apoptotic cell death. Indeed, the increase in glycolytic 
pathway has been linked to increased cell death in neurons (Herrero-Mendez et 
al., 2008). This process can be prevented by the overexpression of G6PD in 
primary neurons (Herrero-Mendez et al., 2008; Vaughn and Deshmukh, 2008). 
Nevertheless, other forms of stress can injure the survival of neural cells and 
concur to oxidative stress. 
Formerly in the 1970s has been introduced the concept of “excitotoxicity” 
claiming that high doses of excitatory neurotransmitters such as glutamate (Glu), 
aspartate (Asp) and cysteine (Cys) might be involved in neuronal degeneration 
(Meldrum, 1993). Glu has been shown to exert a toxic effect via overstimulation 
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of N-methyl-D-aspartate (NMDA)-type glutamate receptors (NMDARs) and 
subsequent increase in calcium ions (Ca+) concentration in the cytoplasm 
(Ferreira et al., 1996; Bai et al., 2013). Increased Ca+ influx through the activation 
of Glu-gated anion channels seems to be an important source of ROS, such as 
NO or hydrogen peroxide, in neuronal cells (Coyle and Puttfarcken, 1993) which, 
in turn, trigger apoptotic cell death (Goldshmit et al., 2001; Pugazhenthi et al., 
2003; Vincent and Maiese, 1999). In addition, NO plays a role as a second 
messenger for inflammatory response by activating the microglia in the brain. 
Microglia are the resident immune system of the brain which originate from the 
extraembryonic endoderm and migrate in the central nervous system during 
embryonic development. Activated microglia are responsible for removal of 
apoptotic cells in the brain and for stimulation of the active immune response 
upon infection, trauma, molecules or protein aggregates-induced toxicity. Indeed, 
activated microglia promote the activation of astrocytes and peripheral immune 
system via production of pro-inflammatory cytokines such as tumor necrosis 
factor- (TNF-), interleukin-1 (IL-1) and free radicals such as NO and 
superoxide (Sankarapandi et al., 1998).  
The involvement of NO in both neuroinflammatory response and oxidative 
stress suggest a possible interplay that might underlie the pathogenesis of 
neurodegenerative diseases such as Parkinson´s disease (PD), Alzheimer´s 
disease (AD), and amyotrophic lateral sclerosis (ALS), in which both of them are 
common features.    
Parkinson’s Disease (PD) is the most common neurodegenerative disease 
with motor symptoms that occurs usually around 55 years age. Most of the cases 
are identified as sporadic (idiopathic PD) late-onset, while only few cases have a 
familiar transmission and are characterized by an early-onset. The hallmarks of 
the pathology are resting tremors, rigidity, postural instability and other non-
motor symptoms such as pain, depression, constipation, sleep disturbances and 
urogenital problems. The molecular hallmark of PD is the formation of insoluble 
aggregates of alpha-synuclein (-syn) protein in the neurons, the so-called Lewy 
bodies or Lewy neurites. Moreover, PD is characterized by the loss of 
dopaminergic neurons in the Substantia nigra pars compacta. PD, as well as, 
other neurodegenerative diseases, is also characterized by mitochondrial and 
lysosomal dysfunction, proteasomal impairment and oxidative stress. Reported 
evidences of oxidative damage in PD include accumulation of protein carbonyls 
and 4-HNE protein adducts in PD brains, decreased levels of antioxidant, such as 
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GSH, ascorbate and vitamin E in brain and plasma from PD patients, increased 
mitochondrial ROS in PD fibroblasts and increased expression of HMOX2 and 
mitoSOX in differentiated neurons from patient-derived iPS cells (Giordano et 
al., 2014). The etiology of the disease is complex, because genetic alteration, 
environmental factors and aging concur with the outcome of the pathology. 
Genome wide association studies (GWAS) have identified several generic risk 
factors that might be implicated in the outcome. These include the 16 “PARK” 
loci, including the PTEN-induced kinase 1 (PINK1 or PARK6), Parkin (PARK2), 
SNCA (PARK1/4), LRRK2 (PARK8), e DJ-1 (PARK7) (Simón-Sánchez et al., 
2009). Interestingly, all of these genes are responsible for mitochondrial 
dysfunctions in familial PD (Subramaniam et al., 2013). The first indication of 
the link between mutations in alpha-synuclein (SNCA) gene and PD dates to 
1997 (Polymeropoulos et al., 1997; Maroteaux et al., 1988). Mutations in SNCA 
gene lead to protein misfolding and/or overexpression and are usually associated 
with increased -syn protein aggregation and toxicity. However, the -syn 
protein function and the molecular mechanisms that lead to -syn aggregation 
and toxicity in dopaminergic neurons are still unclear. Noteworthy, dopaminergic 
neurons are even more susceptible to oxidative stress due to the products of 
dopamine oxidation that represent another source of oxidative stress.  
Even though oxidative stress is extremely common in neurodegenerative 
disease where aging is an important feature, it seems to play an important role 
also in other brain diseases not age-related, such as Rett Syndrome. However, 
whether oxidative stress is a mere consequence of degenerative processes 
initiated by some other factors, for example genetic, or whether oxidative stress 
is an early event that contributes integrally to the etiology of brain diseases is still 
an open question  
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Chapter 2 
 
UNREVEALING OXIDATIVE STRESS IN RETT 
SYNDROME 
 
 
 
2.1 Introduction 
 
Rett Syndrome (RTT, OMIM #312750) is a neurological disease affecting 
almost exclusively girls with an incidence of 1:10.000 live births (Lyst and Bird, 
2015). 
The pathology is characterized by a former, apparently normal, post-natal 
development followed by a development arrest around 6 to 18 months of age. At 
this stage the clinical symptoms arise, and these include loss of acquired motor 
and cognitive skills, including speech, and the insurgence of stereotypical 
movements, breathing disturbances, microcephaly, seizure and mental 
retardation. Most of the cases (from 85 to 94%) are also characterized by a strong 
growth delay that might be one of the first indications of the pathology. 
RTT is a monogenic disorder mostly caused by de novo sporadic loss of 
function (LoF) mutations in the X-linked gene encoding for Methyl CpG binding 
Protein 2 (MeCP2; Amir et al., 1999). Thus, the pathology has a negative 
dominant inheritance in female and, given to the X chromosome localization, it 
is early lethal in hemizygous males. 
MeCP2 gene encodes for two protein isoforms highly expressed, even though 
not exclusively, in post mitotic neurons throughout the brain where are supposed 
to be responsible for normal neuronal function and structural maintenance (Lyst 
and Bird, 2015). Indeed, RTT patients show a reduction in neuronal cell size, 
neuritic length and dendritic spines density. 
MeCP2 binds to DNA at the cytosine site in metilated CpG rich domains, 
where it regulates gene expression and epigenetic modifications. MeCP2 binds 
to methylated DNA mainly through the methyl-binding domain (MBD) even 
though other DNA binding motifs have been describing (Lyst and Bird, 2015). 
DNA methylation is a known signature for gene silencing and MeCP2 has been 
proposed to regulate gene expression via recruitment to DNA of co-repressors 
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and histone deacetylates leading to inhibition of transcription (Nan et al., 1998; 
Jones et al., 1998). Nevertheless, microarray studies have shown the 
downregulation of several genes in MeCP2 null mice supporting its role as 
transcriptional activator (Chahrour et al., 2008). Moreover, Chahrour and 
collaborators (2008) have shown MeCP2 interaction with the transcriptional 
activator CREB on active promoters. One of the main targets of MeCP2 is the 
Brain Derived Neurotrophic Factor (Bdnf), which plays an essential role in 
neuronal survival and plasticity (Filosa et al., 2015).  
Beside its role in gene expression regulation, MeCP2 is also responsible for 
epigenetic modification in the nervous system. MeCP2 has been shown to 
regulate chromatin structure, in particular the structural organization of 
chromocenters and, in turn, in the heterochromatinic architecture in neural cells 
(Bertulat et al., 2012). Moreover, MeCP2 plays a role in alternative splicing 
(Maunakea et al., 2013), miRNA processing (Cheng et al., 2014) and perhaps it 
regulates transposition in neurons (Muotri et al., 2010). 
Despite many studies have been done to understand the function of MeCP2, 
are still unknown the molecular mechanisms that link MeCP2 mutations to the 
pathology outcome. Especially, it is still unknown the role of MeCP2 in brain 
development and physiology (Guy et al., 2011). Most of the mutations causing 
the pathology onset are missense mutations occurring in the DNA binding 
domains that, affecting the MeCP2 binding to DNA, might influence co-repressor 
recruitment and heterochromatin structure, ultimately influencing normal 
neuronal functions (Lyst and Bird, 2015). Important to note, the re-expression of 
MeCP2 protein rescues the phenotype in RTT mouse models. 
During the last decade has emerged that RTT patients have high levels of 
circulating oxidative stress markers (De Felice et al., 2009; Pecorelli et al., 2011; 
Leoncini et al., 2011). De Felice et al. (2014) confirmed redox alterations in two 
RTT mouse models (Mecp2-null e Mecp2-Loss of Function), showing reduced 
antioxidant enzyme activity and increased levels of oxidative stress markers in 
brain tissues. Noteworthy, oxidative stress seems to precede the pathology 
outcome in mouse models of RTT, even though is still unclear the role of 
oxidative stress in disease progression (De Felice et al., 2014).  
Several in vivo and in vitro models are currently available for studying RTT. 
Over the last decades, stem cells have been emerging as a powerful model system 
for several studies.  
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Mouse embryonic stem (mES) cells are derived from the inner cell mass 
(ICM) of a mouse embryo at the blastocyst stage. mES cells can be maintained 
undifferentiated in culture for several passages without losing their 
differentiation potential and are able to differentiate, upon induction, into various 
cell lineages. Several protocols have been established to differentiate stem cells 
in several cell types derived from all the three embryonic germ layers. 
Moreover, it is possible to genetically engineer stem cells in order to obtain 
specific mutant isogenic cell lines. Upon injection into a mouse blastocyst, 
genetically engineered stem cells integrate within the ICM, thus generating a 
chimeric mouse. If the engineered cells colonize germinal tissues of the chimeric 
mouse it is possible to generate, through chimeric mice inbreeding, transgenic 
animals carrying the desired mutation. 
Beside the generation of transgenic animals, it is possible to study the role of 
the gene of interest both in stem cells or stem cell differentiated cell lines, in a 
simplified in vitro model system. For example, the protocol described by Fico et 
al. (2008) is an optimized one for differentiation of mESC into neural and glial 
cells in monolayer, without co-culture, embryoid bodies (EBs) formation, or 
intermediary steps of cell dissociation and replating. The protocol relies on the 
use of the Knock-out serum replacement (KSR)-supplemented medium and is 
able to generate the four different neuronal subtypes (-aminobutyric acid 
(GABA)-ergic, dopaminergic, serotonergic, and motor neurons) after 13 days in 
culture.  
The aim of this work was to investigate about the correlation between 
oxidative stress and Rett syndrome and, in particular on the molecular 
mechanisms that might be involved.  
Taking advantage of the mES cell line carrying the null mutation for MeCP2 
(MeCP2-/Y mES cells; Bertulat et al., 2012), I aimed to identify the molecular 
pathways activated upon oxidative stress stimulation in mES derived neurons and 
to understand whether or not the protein MeCP2 was involved in the protection 
against oxidative stress in neurons. The interest was also to analyze whether 
oxidative stress influenced genes expression as well as functional and 
morphological alterations in Wild type (WT) and MeCP2-/Y mES derived 
neurons in a similar way to what observed in RTT patients.  
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2.2. MATERIALS AND METHODS 
 
2.2.1 mES cells culture 
 
WT and MeCP2-/Y mES cell lines were kindly provided by the Maurizio 
D’Esposito lab (IGB-CNR, Naples). 
Both, WT and MeCP2-/Y were cultured feeder-free on gelatin coated six well 
plates and maintained undifferentiated in LIF containing medium (mES 
Medium). Medium change was performed every day and cells were passaged 
when reach a confluency of c.a. 70-80%, usually every two days as follows. 
 
mES cells passaging protocol 
At least 1 hour before passaging coat 6-well plate using 1 ml of gelatin 
solution per well and incubate at room temperature for 1 hour.  
Warm a sufficient volume of mES medium at room temperature.  
Aspirate the medium from the well and wash twice with 1 ml of PBS1X. Add 1 
ml 0.05% trypsin solution and incubate at room temperature for 10 min. In the 
meantime, aspirate gelatin solution from the well and let it dry. 
Neutralize trypsin solution with addition of 1ml medium and dissociate cells by 
pipetting up and down several times in order to obtain a single cell suspension.  
Transfer the cell suspension at the desired dilution in gelatin coated well 
containing 2 ml of medium. 
Move the plate back and forth to distribute cell suspension and place the plate in 
the incubator. 
 
mES cell freezing protocol 
One confluent well can be passaged in three vials. 
Aspirate medium from the well and wash twice with 1 ml of PBS1X. Add 1 ml 
0.05% trypsin solution and incubate at room temperature for 10 min. 
Neutralize trypsin solution with addition of 1ml medium and dissociate cells by 
pipetting up and down several times in order to obtain a single cell suspension.  
Transfer cell suspension in 15 ml tube and centrifuge at 1000 RPM for 5 min. 
Aspirate the supernatant and resuspend cells in 3 ml of freezing medium (10% 
DMSO in FBS). Transfer 1 ml cell suspension in labelled cryovials and place 
promptly in dry ice. Move and store the frozen vials in the liquid Nitrogen tank. 
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mES cells thawing protocol 
At least 1 hour before passaging coat a 6-well plate using 1 ml of gelatin 
solution per well. Incubate at room temperature for 1 hour.  
Warm a sufficient volume of mES medium at room temperature.  
Thaw the cells by adding 1 ml of warm medium to the frozen pellet. And gently 
transfer the volume in a 15 ml tube containing 8 ml of medium. 
Centrifuge at 1000 RPM for 5 min at room temperature.  
Aspirate the supernatant and gently re-suspend the cells in 2 ml of medium. 
Aspirate the gelatin solution from the well and plate the 2 ml cells suspension.  
Move the plate back and forth to distribute cell suspension and place it in the 
incubator. 
Change the medium the next day. 
 
 
2.2.2 Neural differentiation 
 
Neural differentiation has been performed using the protocol established by 
Fico at al., (2008). 
Briefly, the cells were washed with PBS1X and dissociated in trypsin solution to 
obtain a single-cell suspension. The cells were seeded in gelatin coated six-well 
plates in neuronal differentiation medium (KO Medium). Respectively 1000 
cell/cm2 and 1500 cell/cm2 for WT and MeCP2-/Y mES cells were seeded 
(according to Bertulat et al., 2012). 
The culture medium was replaced every other day until day 4 and afterwards 
every day until day 13. 
 
 
2.2.3 Oxidative burden 
 
At day 13 of differentiation cells were exposed to oxidative stress by 
treatment with Glucose Oxidase (GOX) an enzyme that produces H2O2 in the 
plate via oxidation of the glucose contained in the medium. 
GOX was diluted to different final concentrations (10, 25, 50, 75 and 100 mU/ml) 
in KO Medium. 
The culture medium was replaced with GOX containing medium and incubated 
for 30 min at 37°C. The culture medium was then replaced with fresh medium 
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and cells were harvested at different time points, respectively 1, 3, 5, and 8 hours 
after the pulse with GOX. 
 
2.2.4. Fixation and Immunostaining 
 
At day 13 of differentiation cells were fixed for immunostaining as follows. 
Aspirate the medium and wash once with 1 ml D-PBS1X. 
Fix the cells in 4% paraformaldehyde in PBS1X (4% PFA) for 15 min at room 
temperature. 
Remove the fixation solution and wash three times with 1 ml D-PBS 1X for15 
min at room temperature. 
Perform cell permeabilization and aspecific blocking by incubating 10% normal 
goat serum (DakoCytomation, Glostrup, Denmark)/0,1 % triton X-100 in PBS 
1X for 15 min RT. 
Dilute primary monoclonal anti-III-Tubulin antibody (1:400; Sigma-Aldrich) in 
10% NGS (Dako)/PBS and incubate overnight at 4°C. 
Wash three times in PBS for 5 min at room temperature. 
Dilute secondary antibody in 10% NGS (Dako)/PBS and incubate 1 h at room 
temperature, protect from light. 
Wash three times in PBS for 5 min at room temperature. 
Counterstain nuclei with DAPI (250 ng/mL, Sigma-Aldrich) for 2-3 min, at room 
temperature, protect from light.  
Images were acquired using epifluorescent inverted microscope (Leica-
Microsystem) and processed with FiJi. 
 
 
2.2.5. Western Blotting 
 
Protein isolation 
Total cell lysates were prepared from differentiated mES cells treated with 
GOX at different time points, 1h, 3h, 5h, and 8h, after treatment in 100-500 l 
Tergitol-type NP-40 lysis buffer: 
 Tris-HCl pH 8    20 mM 
 NP40      0.1 % 
 Glycerol     10 % 
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 NaCl      138 mM 
 EDTA pH 8     10 mM 
 H2O MilliQ      
supplemented with: 
 0.5 mM DTT; 
 0.5 mM PMSF; 
 2 mM benzamidine; 
 20 g/l aprotinin; 
 4 g/l pepstatin; 
 10 M leupeptine; 
 10 mM NaF; 
 1 mM Na3VO4; 
 25 mM -glicerophosphate (Sigma-Aldrich) 
 
From 100 to 500 l of lysis buffer was added to each sample according to 
the pellet size and incubated on ice for 25 min, vortexing briefly every 5 min. 
After centrifugation at 14000 RPM for 30 min at 4°C, the supernatants were 
transferred in a new 1.5 ml tube and the pellet were discarded.  
Protein concentrations were determined with Bradford assay by measuring the 
absorbance at 595 nm with the spectrophotometer and relative comparison to 
BSA standard curve. 
Protein lysates were stored at -80°C. 
 
SDS-PAGE and blotting on PVDF 
Total cell extracts were normalized to 10 g and separated on either 10% or 
12.5% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). 
Separated proteins were then transferred on PVDF membrane (Millipore) at 100 
Volt for 1 hour at 4°C. 
Aspecific sites were blocked with 5% nonfat milk solution for 1 hour at room 
temperature and membranes were incubated with primary antibody overnight at 
4°C.  Membranes were washed three times for 10 min at room temperature with 
washing solution and incubated with secondary antibody for 1 hour at room 
temperature. 
The immune complexes were detected by the ECL detection system according to 
the manufacturer’s protocol (Amersham Bioscience). 
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List of Antibodies 
Antigen Host 
species 
Cat. n Supplier Dilution 
P-Erk1/2 rabbit #4376 Cell signaling 1:1000 
Erk1/2 rabbit #4695 Cell signaling 1:1000 
P-JNK rabbit #9251 Cell signaling 1:1000 
JNK rabbit #9252 Cell signaling 1:1000 
P-p38 mouse sc-166182 Santa Cruz 
Biotechnology 
1:1000 
P38 rabbit #9212 Cell signaling 1:1000 
Bcl-2 rabbit #3498 Cell signaling 1:1000 
PARP rabbit #9542 Cell signaling 1:300 
Cleaved 
Caspase-3 
rabbit #9661 Cell signaling 1:1000 
MeCP2 rabbit M9317 Sigma Aldrich 1:2000 
Actin rabbit A2066 Sigma Aldrich 1:2500 
Anti-rabbit goat AP307P Sigma Aldrich 1:10000 
Anti-mouse goat  31431 Thermo 
Fisher 
Scientific 
1:10000 
 
 
2.2.6. Media and Solutions 
 
mES cell medium (mES Medium) 
Dulbecco's Modified Eagle Medium (DMEM)   500 ml 
Fetal bovine serum 15%     90 ml 
Glutamine 2 mM      6 ml 
Sodium pyruvate 1 mM     6 ml 
-mercaptoethanol 1 mM     1.2 ml 
LIF 1000 U/ml 
 
Neuronal differentiation medium (KO Medium) 
Knockout Dulbecco’s minimal essential medium  500 ml 
Knockout Serum Replacement (KSR) (Invitrogen) 15% 90 ml 
Glutamine 2 mM      6 ml 
Penicillin/ streptomycin 100 U/ml    6 ml 
 -mercaptoethanol 0.1 mM     1.2 ml 
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PBS1X       final vol. 5 L 
Na2HPO4       5.75 g 
NaCl        40 g 
KCl        1 g 
KH2PO4       1 g 
H2O MilliQ       Up to 5 L 
 
Trypsin solution      final vol. 1 L 
NaCl        8 g 
KCl        0.4 g 
Glucose       1 g 
NaHCO3       0.59 g 
EDTA        0.29 g 
Trypsin        0.5 g 
H2O MilliQ       Up to 1 L 
 
Acrylamide gel preparation: 
Lower gel       final vol. 10 ml 
       12.5%  10%  
Tris-HCl pH 8.8 1.5 M    2.5 ml  2.5 ml  
Acrylamide 30% (SIGMA)    4.17 ml 3.3 ml  
H2O MilliQ      3.12 ml 4 ml  
SDS 10%      100 l  100 l 
APS 10%      100 l  100 l 
Temed       10 l  10 l 
 
Upper gel 5%      final vol. 5 ml 
Tris-HCl pH 6.8 1 M      630 l 
Acrylamide 30% (SIGMA)     830 l 
H2O MilliQ       3.435 ml 
SDS 10%       50 l  
APS 10%       50 l 
Temed        5 l 
 
 
28 
 
Laemly buffer 4X   STOCK  final vol. 10 ml 
Tris-HCl pH 6.8 0.25 M  1 M   2.5 ml 
SDS 8%       800 mg 
 -mercaptoethanol 20%     2 ml 
Glycerol 40%    100%   4 ml 
bhromo phenol-blue 0.04%  1%   400 l 
H2O MilliQ       Up to 10 ml 
Stored a 4°C 
 
Running Buffer 1X   STOCK   final vol. 1 L 
Tris-Gly 1X    10X   100 ml 
SDS 0.1%    20%   5 ml 
H2O MilliQ       up to 1 L 
 
Transferring Buffer 10X  STOCK  final vol. 1 L 
Tris-Gly 1X    10X   100 ml 
MetOH 10%    100%   100 ml 
H2O MilliQ       800 ml 
 
Blocking Solution   STOCK  final vol. 50 ml 
TBS pH 8 1X    10X   5 ml 
Tween20 0.1%   100%   50 l 
Nonfat Milk 5%      2.5 g 
H2O MilliQ       Up to 50 ml 
 
Washing Solution   STOCK  final vol. 500 ml 
TBS pH 8 1X    10X   50 ml 
Tween20 0.1%   100%   500 l 
H2O MilliQ       Up to 500 ml 
 
TBS10X pH 8   STOCK  final vol. 500 ml 
Tris-HCl pH 8 100 mM  2 M   25 ml 
NaCl 1.5 M    5 M   150 ml 
H2O MilliQ       Up to 500 ml 
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Stripping buffer   STOCK  Final vol. 50 ml 
Tris-HCl pH 6.7 62.5 mM  1 M   6.25 ml 
SDS 2%    20%   5 ml 
H2O MilliQ       Up to 50 ml 
Supplement with -mercaptoethanol 100 mM   (357.5 l per 50 ml) 
 
 
2.3 RESULTS 
 
2.3.1 Neural differentiation of WT and MeCP2-/Y mES cell 
lines. 
 
I used the single-step monolayer differentiation protocol mentioned above 
(Fico et al., 2008) to generate neurons from both WT and MeCP2-/Y mES cell 
lines (Bertulat et al., 2012) and I confirmed the efficient differentiation of both 
cell lines via immunostaining for the pan-neuronal marker III-Tubulin (Fig. 
2.1).  
 
 
Fig. 2.1 Immunostaining for the neural marker III-Tubulin in WT and MeCP2-/Y mES 
derived neurons at day 13 of differentiation.  
 
 
2.3.2 MAPK activation upon oxidative stress stimulation of WT 
and MeCP2-/Y mES cells derived neurons.  
 
Starting from the published data showing increased oxidative stress in RTT 
patients and RTT mouse models I analyzed whether MeCP2 was modulated by 
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oxidative stress. To this aim I tested the effect of oxidative burden on WT and 
MeCP2-/Y mES differentiated neurons. Neurons at day 13 of differentiation were 
treated with Glucose Oxidase (GOX), an enzyme that oxidizing glucose produces 
H2O2. I analyzed the effect of different concentrations of GOX on MeCP2 
expression. 
As shown in Fig. 2.2, MeCP2 expression directly increased depending on 
H2O2 concentration. This result encouraged me to analyze if the MAPK pathways 
were differentially activated in MeCP2-/Y neurons after an oxidative burden. The 
Western blot analysis showed that the level of the active form of Erk 1/2 (P-Erk 
1/2) increased in both WT and MeCP2-/Y derived neurons in a dose-dependent 
manner (Fig. 2.2), although Erk 1/2 was already phosphorylated in untreated 
MeCP2-/Y neurons. GOX treatment induced the activation of P-p38 in both cell 
lines even though the level of P-p38 was lower in MeCP2-/Y mES derived 
neurons compared to the WT counterparts.  
 
 
Fig. 2.2 Dose-dependent MAPKs activation in WT and MeCP2-/Y mES derived neurons 1 
hour after GOX treatment. -Actin was used as loading control.
 
To analyze if the observed MAPKs activation was time dependent, WT and 
MeCP2-/Y neurons were treated with 50 mU/ml GOX. This concentration was 
chosen since, as previously observed, it was sufficient to strongly activate the 
MAPKs. Moreover, neurons detachment was observed at higher GOX 
concentration (data not shown). I analyzed the MAPKs activation at four 
different time points after GOX treatment (1h, 3h, 5 h and 8h). Western blot 
analysis confirmed the differences in MAPKs activation. Indeed, P-Erk 1/2 
activation was strongly activated during the time both in WT and MeCP2-/Y 
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treated neurons, and the maximum activation was observed 1 hour after treatment 
(Fig. 2.3).  
 
 
Fig. 2.3 Time-course MAPKs activation in WT and MeCP2-/Y mES derived neurons after 
50 mU/ml GOX treatment. -Actin was used as loading control. 
 
P-p38 resulted almost not activated in MeCP2-/Y neurons, while in WT 
neurons its activation reached the maximum 3 hours after treatment and persisted 
until 8 hours. Finally, the analysis of JNK activation (P-JNK) showed that this 
pathway was already active in MeCP2-/Y untreated neurons and its activation 
decreased over the time after treatment. Instead, JNK activation reached the 
maximum 3 hours after treatment in WT neurons (Fig. 2.3).  
 
 
2.3.3 Apoptotic response upon oxidative stress stimulation of 
WT and MeCP2-/Y mES cells derived neurons. 
 
As described above, MAPKs can induce either apoptotic or survival response 
after oxidative stress injury. To distinguish the role of MAPKs activation in these 
cellular systems, I analyzed if GOX treatment induced apoptosis in WT and 
MeCP2-/Y neurons. The Western blot analysis for apoptotic markers, 8 hours 
after treatment, showed that oxidative stress induced apoptosis only in WT 
neurons in a dose-dependent manner. Indeed, I observed a dose-dependent 
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cleavage of PARP and Caspase 3 only in WT neurons (Fig. 2.4). On the contrary, 
the anti-apoptotic marker Bcl2 was highly expressed in MeCP2-/Y neurons.  
 
 
Fig. 2.4 Dose-dependent apoptotic pathway activation in WT and MeCP2-/Y mES derived 
neurons 8 hours after GOX treatment. -Actin was used as loading control. 
 
 
2.4 CONCLUSIONS 
 
The first indication of oxidative stress in Rett Syndrome dates to 1987 when 
reduced level of the antioxidants GSH and vitamin E where detected in a single 
RTT patient (Sofic et al., 1987). Over the time, mounting evidences suggested the 
hypothesis that oxidative stress might play an important role in RTT 
pathophysiology. High levels of lipid peroxidation products, such as isoprostanes 
(IsoP) and 4-HNE, and level of oxidized proteins have been observed in plasma 
of RTT patients and both in plasma and brain of RTT animal models (De Felice 
et al., 2014). Regarding the possible role of oxidative stress in the RTT etiology, 
oxidative stress-mediated CpG modification has been reported to inhibits MeCP2 
binding to DNA (Valinluck et al., 2004)  
This work was made with the interest to investigate the possible role of 
MeCP2 protein in oxidative stress response. I took advantage of a mES cell line 
mutant for MeCP2 and the possibility to easily differentiate mES in neuronal cell 
to analyze MeCP2 function specifically in neurons. I differentiated both WT and 
MeCP2-/Y mES cell lines into neuronal cells to investigate the role of MeCP2 in 
oxidative stress-mediated cellular response. 
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As expected, oxidative treatment of WT and MeCP2-/Y neurons activated 
the MAPK pathway. Activation of MAPK pathways following oxidative stress 
has been described to induce different outputs. Indeed, according to the intensity 
and persistence of the stimulus, they can either increase the survival potential of 
the cells by inducing the transcription of several antioxidant enzymes or 
determine cell death. 
Although my data do not permit to determine which MAPK is essential to 
induce apoptosis in WT cells, the activation of ERK and JNK in the untreated 
MeCP2-/Y neurons suggested a possible role of these MAPK in the induction 
and maintenance of the anti-apoptotic protein Bcl2 during oxidative stress. 
The usage of specific inhibitors will allow to discriminate the precise role of 
the analyzed MAPK pathways.   
The data presented also suggest a block of the apoptotic pathway induced by 
oxidative stress in MeCP2-/Y neurons. In particular, MeCP2 might act as a 
modulator of the expression of anti-apoptotic proteins, such as Bcl2.  
It is important to note that neurodegeneration has not been observed in RTT 
patients. My data suggest that in absence of MeCP2, oxidative stress induced 
damage in neuronal cells, as previously described in mice, although the cells 
cannot activate the apoptotic pathway due to the overexpression of Bcl2. 
During the last years, a new model system has been emerging as a very 
promising tool to model brain development and disease: three dimensional (3D) 
cerebral organoids (Pașca, 2018). This model system has already been used to 
model several brain diseases including Rett Syndrome (Mellios et al., 2018) and 
suggest that this technology has the potential to unveil aspects of brain 
functioning that are still hidden so far. 
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Chapter 3 
 
CEREBRAL ORGANOID: A NEW MODEL FOR BRAIN 
DISEASES 
 
 
 
3.1 INTRODUCTION 
 
In recent years, new protocols have been established to generate three-
dimensional (3D) cultures that mimic the physiology and the developmental 
process of an actual human organ (Pașca, 2018). In particular, a special effort has 
been made on generating brain specific 3D cultures because our knowledge of 
human brain development is largely derived from studies in animal models, 
particularly rodents (Renner et al., 2017). 
Albeit, numerous are the differences between the rodent and human brain 
structure and development. For example, the rodent cerebral cortex is smooth, 
while human cortex is convoluted due to the big surface expansion during 
evolution. The main source of interneurons in human are the ganglionic 
eminences (GE) of the ventral telencephalon and the ventricular 
zone/subventricular zone (VZ/SVZ) of the dorsal telencephalon, while in rodents 
the interneurons are generated only in the GE.  
The primate SVZ contains a much larger population of neural progenitors 
compared to rodent brain. In addition, the rodent brain misses some regions such 
as the Broca and Wernicke areas or the prefrontal granular cortex. 
These are only few of the several differences between the rodent and primate 
brain. 
Some limitations of mouse models have been overcome by the introduction 
of human pluripotent stem cells generated via cellular reprogramming. The 
expression of the “magic quartet” of transcription factors (Oct3/4, Sox2, c-Myc, 
and Klf4) in differentiated somatic cells induces their conversion into pluripotent 
stem (iPS) cells (Takahashi and Yamanaka, 2006). iPS cells can be propagated 
in culture in an undifferentiated state as well as induced to differentiate in vitro 
into all the three germ layers derivatives, including neural cells. The use of human 
iPS cells-derived neurons, thus, allows studying differentiation patterning and 
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molecular pathways involved in both health and disease, in a human-specific 
model. Although numerous differentiation protocols have been established to 
generate a variety of neural cell types from pluripotent stem cells, two-
dimensional (2D) cultures do not allow to fully recapitulate the complex 
architecture and functioning of the developing human brain. 
Instead, 3D cultures generated from human stem cells, offer an 
unprecedented opportunity to model and study human brain development and 
diseases (Clevers, 2016; Di Lullo and Kriegstein, 2017). 
By relying on the self-aggregation and self-organization capacities of 
pluripotent stem cells, it is possible to generate a complex structure that mimics 
the cytoarchitecture of an actual human brain. These so-called cerebral organoids 
contain several neuronal cell types that organize in brain-like structure including 
forebrain, midbrain, retina, choroid plexus as well as ventricular and 
subventricular zones. 
Cerebral organoids contain also organized germinal zones and forebrain-
organizing centers that are generated according to the in vivo spatial and temporal 
patterning. Moreover, both radial and tangential migrations of cortical neuron 
populations are observed in cerebral organoids (Renner at al., 2017). 
Several studies have shown that differentiating cerebral organoids display an 
expression profile and epigenetic signature that correlate with fetal neocortex 
during human in vivo development (Camp et al., 2015; Luo et al., 2016; Quadrato 
et al., 2017). 
Cerebral organoids can be grown for extended periods of time leading to the 
formation of structurally-defined synapses and dendritic spines that, together 
with the acquisition of firing potential, indicate that organoids can reach a high 
rate of maturation (Quadrato et al., 2017). 
It is also possible to generate brain region-specific organoids, such as 
forebrain, midbrain and retinal organoids or cortical spheroids by addition of 
external factors that drive induction of unique tissue identities (Eiraku et al, 2008; 
Chambers et al, 2009; Kadoshima et al, 2013; Mariani et al, 2015; Pasca et al, 
2015; Jo et al., 2016; Qian et al, 2016). Of course, these brain region-specific 
organoids lack the interactions between different regions constituting the brain 
(Renner et al., 2017) 
Cerebral organoids have been used to model neocortex congenital diseases 
such as microcephaly and macrocephaly (Lancaster et al., 2013) as well as to 
model autism spectrum disorders (ASD; Forsberg et al., 2018), including Rett 
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Syndrome (Mellios et al., 2018), or Zika Virus pathology (Qian et al., 2016; 
Watanabe et al., 2017). Therefore, these studies suggest the possibility to study 
the contribution of environmental factors, such as drug exposure, viral infection, 
hypoxia or oxidative stress, and epigenetic alterations during early brain 
development. Epigenetic factors might play important role in the neurobiology 
of autism by regulating processes, such as cell proliferation, differentiation and 
survival, as well as neurite outgrowth, thereby influencing prenatal brain 
development (Forsberg et al., 2018). 
Thus, cerebral organoids are well suited to study developmental diseases, but 
it is more challenging to model neurodegenerative disease such as PD, AD, ALS 
and HD. These pathologies are characterized by a late-onset. Idiopathic PD, for 
example, occurs typically around 50-60 years old age, while cerebral organoids, 
given their relatively poor maturation, better resemble early brain development. 
Nevertheless, the use of cerebral organoids as model system for AD has 
already been reported. Cerebral organoids generated from AD patients-derived 
iPS cells recapitulate disease neuropathological phenotypes such as amyloid 
aggregation and tau protein hyperphosphorylation (Raja et al., 2016).  
Beside the difficulty to model an adult brain, there are other limitations in 
the use of cerebral organoid as model system for brain studies. The structure that 
arises from 3D differentiation is not fully comparable to the architecture of an 
actual human brain and lack of rostro-caudal and dorso-ventral axes. Moreover, 
cortical lamination in cerebral organoid is incomplete and there is lack of 
vascularization in innate immune system. Lack of vascularization and microglia 
are major limitations that current research aims to overcome. The resident 
microglia, indeed, beside their role as immune system players, are directly 
involved in neural differentiation and maturation in the developing brain and 
vascularization is essential to support the oxygen and nutrient supply in the most 
inner part of the 3D culture. Its absence makes the long term culturing of cerebral 
organoids challenging. So far, vascularized organoids have been obtained via 
organoid engraftment in mice brains (Mansour et al., 2018). 
Even though 3D cultures do not allow the full reconstruction of an actual 
functional brain, they recapitulate more faithfully the process of the human-
specific brain development than mouse models and 2D culture systems. 
The aim of this study was to first characterize the growth and differentiation 
of cerebral organoids (hereafter referred to as Minibrains, (MBs)) derived from 
a Wild type (WT) NAS6 iPS cell line and test strategies to make MBs generation 
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more stable and reproducible. Secondly, to use MB as model system for 
neurodegenerative diseases, especially PD. For this aim, I used a SNCA 
overexpressing iPS cell line to generate MB carrying one of the main genetic risk 
factors for PD in order to investigate the mechanisms that lead to -syn protein 
aggregation and toxicity. 
Since oxidative stress is a key phenomenon in PD pathology, I assessed 
whether SNCA overexpressing MBs show signs of oxidative stress. I sought to 
verify if MBs could recapitulate this key characteristic of PD thus allowing their 
use to study the mechanisms underlying the interplay between -syn protein 
accumulation and oxidative stress.  
 
 
3.2 MATERIALS AND METHODS 
 
3.2.1 Human iPS cell culture 
 
hiPS cell lines 
The NAS6 iPS cell line used in this study were obtained from the lab of Tilo 
Kunath (Devine et al., 2011). SNCA-overexpressing NAS6 iPS cell line has been 
generated by Dr. Salvador Rodriguez-Nieto from Peter Heutink´s lab via 
lentiviral transduction with SNCA-RFP virus (Fig. 3.8). mCherry-tagged SNCA 
gene was cloned under the constitutive EF1 promoter. Positive transduced cells 
were selected with blasticidine (10 µg/ml; InvivoGen) two days after 
transduction. 
 
hiPS cell culture 
WT NAS6 and SNCA overexpressing-NAS6 human iPS cell lines were 
maintained and propagated in feeder-free conditions in E8 flex medium 
supplemented with E8 flex supplement. Cells grew as colonies on MatrigelTM 
coated 6-well plates and were passaged as aggregates when they reach a 
confluency of c.a. 70/80%, usually every 4-7 days as follows. 
At least 1 hour before passaging MatrigelTM dilute (according to the 
manufacturer) in cold DMEM/F12 medium to coat a 6-well plate using 1ml of 
diluted MatrigelTM per well and incubate at 37°C for 1 hour.  
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Passaging with Gentle cell Dissociation Reagent 
Gentle cell Dissociation Reagent (GDR) is an enzyme-free reagent suitable 
for the dissociation of both human embryonic stem (ES) cells or human induced 
pluripotent stem (iPS) cells into cell aggregates for routine passaging or into a 
single-cell suspension. 
Warm a sufficient volume of medium at room temperature. Do not warm medium 
in the water bath. 
Use the microscope to visualize regions of differentiation and mark those on the 
bottom of the plate. 
Remove regions of differentiation by aspiration. 
Aspirate medium from the well and add 1 ml of GDR. Incubate at room 
temperature for 6-7 min.  
Aspirate the GDR and add 1 ml of E8 flex complete medium. Detach the colonies 
by pipetting two-three times and transfer in a 15 ml tube containing a volume of 
E8 flex medium necessary for the appropriate dilution (usually 1:10). 
Pipette once the suspension to break up the colonies in order to obtain a 
suspension of c.a. 100 m aggregates. 
Aspirate the MatrigelTM and plate the cell aggregates at the desired dilution. 
Move the plate back and forth to distribute cell aggregates and place the plate in 
the incubator. 
Media change is required the day after passaging and every other day. 
 
hiPS cell freezing protocol 
One confluent well can be passaged in two vials. 
Pre-treat the cells with 2 mM of thiazovidin for 1 hour at 37°C. 
Label cryovials. 
Aspirate medium from the well and add 1 ml GDR per well. Incubate at room 
temperature for 6-7 min. 
Aspirate GDR and add 1 ml of cold freezing medium (10% DMSO in KSR).  
Detach the colonies using a cell lifter and transfer the aggregates in a 15 ml tube 
containing cold freezing medium. Pipette once to break up the aggregates and 
transfer 1 ml in labelled cryovials. Place vials in a precooled box and transfer 
immediately to -80°C freezer. Move and store the frozen vials in the liquid 
Nitrogen tank. 
 
 
39 
 
iPS cells thawing protocol 
Thaw MatrigelTM overnight on ice at 4°C. 
Dilute MatrigelTM in cold DMEM/F12 medium and coat the 12 well plate with 
500 l of diluted MatrigelTM for 1 h at 37°C. 
Thaw the cells by shaking the vial in a water bath set at 37°C. Let only a small 
pellet to stay frozen. 
Add 1 ml of medium to the cells drop wise and gently transfer the volume in a 
15 ml tube containing 8 ml of medium. 
Centrifuge at 230 g for 3min at room temperature.  
Aspirate the supernatant and gently re-suspend the cells in 2 ml of medium 
supplemented with thiazovidin 2 M taking care to maintain the cells as 
aggregates. 
Aspirate the MatrigelTM from the well and plate the cells at different dilutions. 
This gives the flexibility when the cells will be ready.  
Move the plate back and forth to distribute cell aggregates and place it in the 
incubator. 
Change the medium the next day without rock inhibitor. Hereafter medium can 
be refreshed every alternate day if using Essential 8 flex medium. 
 
 
3.2.2 Cerebral organoid 
 
Cerebral organoids have been generated using the protocol established by 
Lancaster et al. (Lancaster and Knoblich, 2014) with few modifications as 
follows. 
 
Embryoid Body formation 
Cells have to be of high quality without sign of differentiation. 
Pre-treat iPS cells with10 μM Rock inhibitor (RI; Y-27632) for 1 hour at 37°C. 
Remove the medium from the well and wash the cells with 1 ml D-PBS 1X 
without calcium and magnesium. 
Remove D-PBS and add 1 ml of Accutase per well. Incubate for 25 min at 37°C. 
Pipette up and down to obtain a single cell suspension and transfer in a 15 ml 
tube containing 7 ml of hES medium without bFGF and RI. 
Centrifuge at 270 g for 5 min. Carefully remove the supernatant. Avoid 
disturbing the cell pellet.  
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Resuspend the cells in 3 ml hES medium supplemented with 50 M RI and 4 
ng/ml bFGF. 
Mix 20 l of cell suspension with an equal volume of trypan blue and count the 
live cells using an automated cell counter. 
Use the average of two replicates to calculate the cell density. Prepare the desired 
cell dilutions in hES medium supplemented with 50 M RI and 4 ng/ml bFGF 
and seed 150 l in each well of an ultra-low attachment U-shaped 96 well plate. 
After 24 hours, small embryoid bodies (EBs) are generated in culture. 
At day three of differentiation feed the EBs by carefully removing half of the 
volume. Add 1 volume of hES medium without RI and bFGF.  
Culture EBs for 2-3 more days until they reach a size between 500 and 600 m. 
 
Neural Induction 
When EBs reach a diameter of 500-600 m and show bright and smooth 
edges, typically at day 6, transfer them into neural induction (NI) medium in 
ultra-low attachment 24 well plates. 
Use wide bore 200 l tips to aspirate the EB. Wait until the EB settle at the bottom 
of the tip and let the EB fall in the well of a 24 well plate containing 500 l of NI 
medium. Avoid transfer old EB medium. 
Feed Neuroepithelial Tissues every other day. For media change tilt the plate and 
let the tissues settle on the bottom. Carefully remove half of the existing medium 
and add 500l of fresh NI medium. Culture Neuroepithelial tissues in NI medium 
for typically 4-5 days. After neural induction a translucent tissue with radially 
organized cells should appear.  
Move to Matrigel embedding step to allow the growth and differentiation of the 
neuroepithelium into MB.  
 
Matrigel Embedding of neuroepithelial tissues in hanging drop  
MatrigelTM embedding step was performed in hanging drops on the lid of 10 
cm Petri dishes to avoid the risk of contamination that might arise from the use 
of parafilm dimples. 
Approximately 15 to 20 MatrigelTM embedded MB fit on the lid of a Petri dish. 
Enough Petri dishes have to be used according to the number of neuroepithelial 
tissues to be transferred.  
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Procedure: 
Thaw MatrigelTM aliquots on ice at 4°C and warm N2B27 medium without 
vitamin A (VitA) at 37°C. 
Use wide bore tips to transfer tissues one by one from the well to the lid of the 
24-well plate.  
Carefully, remove the excess of medium surrounding the tissue with an uncut 200 
μl tip. 
Take 15l of thawed MatrigelTM using the wide bore tip and suck the tissue in 
the same tip. 
Make a droplet on the lid of a Petri dish filled with 15 ml of PBS 1X (this is 
needed to avoid that MB dry during the incubation). Be careful that the tissue is 
positioned in the middle of the droplet. 
Invert the lid onto the Petri dish and put back in the incubator. Incubate for 30 
min at 37°C to let the MatrigelTM solidify. 
Spray the forceps with 70% ethanol and let it evaporate for 1-2 min. 
Invert the lid and use a cut 1 ml tip to add the warm N2B27–VitA medium to the 
embedded tissues. Using the warm medium will help to detach the MatrigelTM 
droplets from the lid.  
Transfer the floating tissues in an ultra-low attachment 6-well plate. Up to four 
tissues can be cultured in the same well. Continue culturing the tissue droplets in 
a CO2 incubator.  
Change the medium after 24 hours.  
Tilt the plate and let the tissues settle on the bottom. Use an uncut 1 ml tip to 
gently remove the medium from the well. Remove as much medium is possible. 
Gently add 4ml of fresh medium on the wall of the plate without disturbing the 
tissues. 
 
Cerebral organoid differentiation 
After 4 days of culture in N2B27–VitA, cerebral organoids were moved to 
the final differentiation medium N2B27+VitA as follows. 
Tilt the plate and let the organoids seat on the bottom of the well. Carefully 
remove the N2B27–VITA medium and gently replace it with N2B27+VitA. 
From now on, culture the organoids on an orbital shaker set at 100 RPM and 
perform complete medium change every three/four days. 
Cerebral organoids have been harvested at different time points and processed 
for RNA isolation or immunostaining. 
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3.2.3 RNA isolation and qPCR 
 
RNA isolation 
RNA isolation has been performed from whole organoids using RNeasy Mini 
Kit (Cat No./ID: 74106) from QIAGEN.  
MBs were harvested at five time points of differentiation (d11; d32; d60; d90; 
d120) using a wide bore 200 l tip for not yet embedded MB or a cut 1ml tip for 
MatrigelTM embedded MB and 1 MB was transferred in a 2 ml centrifuge tube.  
Excess culture medium was carefully aspirated and MB were washed with 500 
l of D-PBS 1X. This step was performed on ice. RLT buffer was added to MB 
(respectively 350 l for not yet embedded MBs and 700 l for MatrigelTM 
embedded MB).  Samples were stored at -80°C until they have been processed. 
Contaminating DNA removal was performed trough DNase treatment. 
RNA concentrations were measured using Nanodrop 2000 and RNA integrity 
and RIN were determined on a Bioanalyzer 2100 system (Agilent Technologies 
Inc.). Low quality samples were excluded from the further analysis.   
 
cDNA synthesis 
cDNA was synthesized from 1 g of RNA using Superscript III reverse 
transcriptase (RT) (Thermo Fisher Scientific) as follows: 
 
1st mix 
• RNA 1 g    12 l 
• Oligo dT 0,4 g/ul   0,5 l 
• Random decamers 50 M  0,5 l 
• dNTPs 10 mM   1 l 
 
Reaction was performed as follows: 
Step1. 65°C x 5 min 
Step2. 4°C x 2 min 
 
2nd mix 
• 1st mix    14 l 
• Buffer 5X    4 l 
• DTT 100 mM    1 l 
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• RNase OUT 40 U/l   0,5 l 
• SuperScript III RT 200 U/l  0,5 l 
 
Reaction was performed as follows: 
Step1. 25°C x 5 min 
Step2. 50°C x 1 hour 
Step3. 70°C x 15 min 
 
cDNAs were stored at -20°C. 
 
Real-time PCR 
qPCR was carried out in triplicate on a QuantStudio real time PCR system 
(Thermo Fisher Scientific). 
 
Reaction mix: 
• cDNA         12 ng 
• SYBR Green PCR master mix 2X (Thermo Fisher Scientific)  5 l 
• Primer Pair 10 μM       0,4 l 
• H2O         1,6 l 
• Final Volume        10 l
   
The qPCRs were performed with QuantStudio 12K flex instrument from Applied 
Biosystem using the thermocycler parameters as follows: 
 
Hold stage:  Step1.  95°C x 20 sec 
PCR stage:  Step1.  95°C x  
    Step2.  62°C x 30 sec 
Melt Curve stage:  Step1.  95°C x 15 sec 
    Step2. 60°C x 1 min 
    Step3. 95°C x 15 sec 
 
Normalized relative quantities (RQ) were calculated using Thermo Fisher 
analysis tool on Cloud with TBP, OAZ1 and RPLPO as reference targets 
(Hellemans et al., 2007). 
 
 
44 
 
Primer list: 
Gene Forward Primer Sequence 
(5’-3’) 
Reverse Primer Sequence 
(3’-5’) 
Amp 
Length 
BRACHY
URY 
TGCTTCCCTGAGACCCAGTT GATCACTTCTTTCCTTTGCATC
AAG 
121 bp 
BRN2 CGGCGGATCAAACTGGGATTT TTGCGCTGCGATCTTGTCTAT 216 bp 
CUX2 CGAGACCTCCACACTTCGTG TGTTTTTCCGCCTCATTTCTCTG 173 bp 
DLG4 TCGGTGACGACCCATCCAT GCACGTCCACTTCATTTACAAA
C 
114 bp 
GATA4 TCCAAACCAGAAAACGGAAG GAAGGCTCTCACTGCCTGAA 78 bp 
HMOX1 AAGACTGCGTTCCTGCTCAAC AAAGCCCTACAGCAACTGTCG 247 bp 
MAP2 CTCAGCACCGCTAACAGAGG CATTGGCGCTTCGGACAAG 95 bp 
NANOG CCCCAGCCTTTACTCTTCCTA CCAGGTTGAATTGTTCCAGGTC 97 bp 
NCAM1 TGTCCGATTCATAGTCCTGTCC CTCACAGCGATAAGTGCCCTC 82 bp 
OAZ1 AGCAAGGACAGCTTTGCAGTT ATGAAGACATGGTCGGCTCG 68 bp 
POU5F1 CTTGAATCCCGAATGGAAAGG
G 
GTGTATATCCCAGGGTGATCCT
C 
164 bp 
OTX1 GCCTCCCCTTCCAGTCTTTC GGGCAGAAACACGCCAGTTA 140  bp 
PAX6 GTGTCCAACGGCTGTGTGAG CTAGCCAGGTTGCGAAGAAC 254 bp 
RPLPO CCTCATATCCGGGGGAATGTG GCAGCAGCTGGCCACCTTATTG 95 bp 
SYN1 TGCTCAGCAGTACAACGTACC GACACTTGCGATGTCCTGGAA 110 bp 
SNCA AAGAGGGTGTTCTCTATGTAGG
C 
GCTCCTCCAACATTTGTCACTT 106 bp 
SOD1 GGTGGGCCAAAGGATGAAGAG CCACAAGCCAAACGACTTCC 227 bp 
TBP TTCGGAGAGTTCTGGGATTGC CACGAAGTGCAATGGTCTTTAG 95 bp 
TRDX1 ATGGGCAATTTATTGGTCCTCA
C 
CCCAAGTAACGTGGTCTTTCAC 115 bp 
 
 
45 
 
3.2.4 Histology and immunostaining 
 
MBs were harvested for immunostaining at day 45 and 75 of differentiation. 
Sample were prepared following the Lancaster protocol with few modifications 
(Lancaster and Knoblich, 2014) as follows. 
 
Fixation and sucrose/gelatin embedding 
Use a cut 1 ml tip to transfer MB to a standard 24-well plate. Aspirate the 
medium and wash once with 1ml D-PBS1X. 
Fix the tissue in 4% PFA for 45 to 60 min at room temperature. 
Remove the fixation solution and wash three times with 1 ml D-PBS 1X for 10 
min at room temperature.  
Replace D-PBS with 1 ml 30% sucrose solution in D-PBS and incubate overnight 
at 4°C. 
The day after, thaw gelatin-sucrose solution and warm it at 37°C. 
In the meantime, make the molds using aluminum-foil.  
Equilibrate the tissue at 37°C for 20 min, then replace the sucrose solution with 
warm sucrose-gelatin solution. Keep the sucrose-gelatin solution warm to avoid 
the polymerization. 
Put a small amount of warm sucrose-gelatin solution into the mold just to make 
a layer on the bottom. Then, use a cut 1 ml tip to transfer MB from the well and 
position in the center of the mold. 
Put immediately in dry ice to freeze the tissue and store at -80°C. 
 
Cryosectioning 
MB were cut in m sections using the Leica Cryosat. All the sections have 
been collected on Super-frost Plus glasses and stored at -80°C. 
 
Protocol for immunostaining on frozen sections on glasses 
Thaw glasses for 15 min at room temperature. 
Rehydrate the tissue and remove the sucrose/gelatin solution by rinsing glasses 
with PBT 0.2%. 
Wipe the excess of liquid and draw hydrophobic circles around the slices with 
the Pap-pen. Let the liquid dry for 2 min. 
Perform permeabilization and blocking in 1% Triton-X, 10% FBS, 1% BSA, 
0.02% NaN3 in PBS 1X for 1 hour at room temperature.  
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Dilute primary antibody in 0.2% Tween-20, 1% BSA, 0.02% NaN3 in PBS 1X 
and incubate overnight at 4°C. 
Wash three times in PBT 0.2% for 15 min at room temperature 
Dilute Alexa FluorTM-conjugated secondary antibody (Invitrogen) in 0.2% 
Tween-20, 1% BSA, 0.02% NaN3 in PBS 1X and incubate for1 hour at room 
temperature (protect from light). 
Wash three times in PBT 0.2% for 15 min at room temperature 
Dilute stock solution of Hoechst 33342 (10 mg/ml) 1:10000 in PBT 0.2% and 
incubate 4 min at room temperature (protect from light). 
Rinse with PBT (protect from light). 
Mount with Antifade medium. Store the glasses at 4°C protected from light. 
Images were acquired using either a Leica TCS SP8 or a Zeiss Axiovert 
microscope and processed with the respective softwares. 
 
List of Antibodies 
Antigen Host 
species 
Cat. n Company Dilution 
TUJ-1 rabbit T200 Sigma 1:1000 
MAP-2 mouse MAB3418 Millipore 1:250 
PAX-6 rabbit 901301 Biolegend 1:300 
NESTIN mouse MAB5326 Millipore 1:1000 
CTIP2 rat AB18465 Abcam 1:300 
BRN2 rabbit 12137 Cell signaling 1:1000 
 
 
3.3 RESULTS 
 
3.3.1 Minibrain generation using different seeding cell density 
conditions 
 
I used the protocol described by Lancaster and collaborators (2014) to 
generate Minibrains (MB) from the WT NAS6 iPS cell line. 
Since each cell line has a unique behavior in term of proliferation rate and 
differentiation commitment, I tested three different seeding cell density 
conditions (S1: 9000 cell/well; S2: 10000 cell/well; S3: 12000 cell/well) in order 
to find the one that allows the more robust generation of MB. 
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I followed the differentiation via brightfield images to monitor if MBs reach the 
proper size and shape at several steps of the differentiation protocol, according 
to Lancaster et al. (2014).  
  
Fig. 3.1 Seeding cell density conditions for generating WT NAS6 MB. Cells seeded as single-
cell suspension aggregate to form embryoid body (EB) structures. At day 3 of differentiation EB 
reach a size around 300m. At day 6 of differentiation EBs reach a size around 600m. At d13 
of differentiation (2 days after MatrigelTM embedding) MB initiate differentiation and start to 
extrude neurites out of the neuroepithelial tissue. MBs from the three conditions do not show 
relevant morphological differences at none of the stage of differentiation. 
 
Next, I harvested from 2 to 5 MBs at four time points during differentiation (d11, 
d32, d60 and d90 of differentiation) from three independent experiments and 
analyzed the expression of neural specific differentiation markers via qPCR. In 
particular, I selected pluripotency markers (NANOG, POU5F1), neural precursor 
markers (PAX6, OTX1) and mature neuron markers, including pan neuronal 
markers (MAP2, NCAM1, SYN1) and cortical markers (BRN2, CUX2, DLG4) 
to have an overall comprehension of MB differentiation.  
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The first data that emerged from the qPCR analysis is the high inter- and intra-
experiment gene expression variability in MBs generated from all the three cell 
density conditions.  
The second observation that can be drawn from this analysis is concerning the 
trend of differentiation. Gene expression for pluripotency markers was almost 
undetectable already at d11 of differentiation in MBs from all the three cell 
density conditions.  
 
Fig. 3.2 qPCR analysis for pluripotency markers and neural precursor markers in WT 
NAS6 MB from seeding density conditions. Two-way ANOVA followed by Turkey´s multiple 
comparisons test. # for p < 0.05; #### for p < 0.0001; ** for p < 0.005 
 
On the other hand, neural precursor genes expression was high in MB at d11 
of differentiation. Albeit, while OTX1 expression decreased after d11 of 
differentiation, PAX6 expression stayed high at all the subsequent time points 
analyzed (d32, d60, d90; Fig. 3.2). Mature neuron specific gene expression 
increased starting from d32 of differentiation and increased considerably and 
consistently over the time. In particular, MBs expressed high level of mature 
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neuron markers (MAP2; NCAM1; SYN1; CUX2; BRN2; DLG4) at d60 of 
differentiation (Fig. 3.3). 
 
Fig. 3.3 qPCR analysis for mature neuron markers in WT NAS6 MB from seeding density 
conditions. Two-way ANOVA followed by Turkey´s multiple comparisons test. # for p < 0.05; 
#### for p < 0.0001; * for p < 0.05; ** for p < 0.005 
 
The experiments were carried out to find the best seeding cell density conditions. 
Therefore, I performed a two-way ANOVA statistical test on gene expression 
data sets. The analysis indicated that the differences among the three cell density 
conditions were slightly significant only at d90 time point and suggested that the 
best seeding condition for WT NAS6 iPS cell line is S2 (10000 cell/well). 
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Experiments for total RNA-seq analysis of MB at different stage of 
differentiation are currently ongoing. These experiments will allow to analyze 
the complete expression pattern of MB during differentiation and maturation. 
 
 
3.3.2 MBs contain human brain-like structures 
 
To understand the internal structural organization of MB, I performed 
immunostaining on frozen sections for both neural precursor and mature neuron 
markers. 
Staining of MBs at day 75 of differentiation showed that MBs contain 
structures that resemble the subventricular zone of the human brain (red arrow; 
Fig. 3.4). Moreover, these structures retained the overall organization in which 
neural precursor cells (Nestin+) localized in the most inner layers, while mature 
neurons resided in the outer part of these structures. 
PAX6 is a neural precursor marker that in vivo is expressed in both outer 
Radial Glia (oRG) in the outer subventricular zone and in intermediate 
progenitors. The oRG is the major source of cortical neurons in vivo. Similarly, 
PAX6+ cells in MB localized in subventricular-like structures as well as they 
were spread through the organoid. Cortical neurons, instead, were located outside 
of these subventricular-like structures in MBs (CTIP2+ and BRN2+ cells 
(arrowhead); Fig. 3.4). These results indicated a parallel between the organization 
of MBs and the in vivo brain also suggesting the concomitant differentiation and 
migration of neurons in the subventricular-like zone in an inside-out fashion. 
Differentiating cortical neurons, moreover, organized to form layers typical of 
the human brain cortex in which it was possible to identify early cortical neurons 
in the deeper layer (CTIP2+ cells; Fig. 3.4) and late cortical neurons in the upper 
layers (BRN2+ cells; Fig. 3.4) although cortical layering in MB was incomplete. 
I identified BRN2+ cells also in the subventricular-like structure (arrow; Fig. 
3.4) and this might be because BRN2 has been shown to be expressed also in 
neural progenitor cells (Dominguez et al., 2013). All together, these data 
indicated that MBs contain areas that resemble the human brain structures, such 
as the subventricular-like zones, and the neural populations originated in the MBs 
have characteristic localizations similar to those observed in vivo.  
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Fig. 3.4 Immunostaining analysis on WT NAS6 MBs at day 75 of differentiation. 
Representative images of neural sub-population localization. The red arrow indicates the 
subventricular-like structure that is possible to identify in the MBs. Scale bars: 50 m 
 
 
3.3.3 Protocol adaptation with SMAD inhibitors 
 
The protocol for generation of cerebral organoid was characterized by a high 
batch to batch variability that was reflected also by the high gene expression 
variability that I observed (described above). 
Beside the high variability that characterizes MB generation, the presence of cell 
types derived from other embryonic origins in 3 and 6 months old MBs has been 
reported (Quadrato et al., 2017). This recent study reported that, among the neural 
subpopulations, MBs contained mesodermal cells indicating that the neural 
commitment was not exclusive. This may be due by the absence of any growth 
factor to stimulate neural differentiation. On the other hand, it is also known that 
ectoderm specification is the result of the default differentiation pathway. 
Mesoderm and endoderm are generated during embryonic gastrulation upon 
accomplishment of epithelial to mesenchymal transition (EMT). During 
gastrulation, epiblast cells undergo EMT through conversion of cell-adhesion 
proteins (E-cadherins). This process is known to be mediated by the activation of 
the Wnt/-catenin and the TGF-beta/BMP-induced SMAD signaling pathways. 
The efficacy of SMAD inhibitors has already been reported in 2D hiPS neural 
differentiation protocols (Chambers et al., 2009).  
Thus, I thought that the use of SMAD inhibitors, hereafter referred to as small 
molecules, could have been useful to inhibit differentiation of meso-endodermal 
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cells and push differentiation towards neural fate, ultimately resulting in a more 
reproducible MB generation. 
Therefore, I tested the efficacy of SMAD inhibition during early stages of 
3D MB differentiation. 
I selected the first 6 days of differentiation to test the effect of small 
molecules treatment. During this time frame, cells are fed with basal hES medium 
and it is possible that some cells escape the default neural commitment and are 
committed for meso-endodermal specification.  
 
Fig. 3.5 SMAD inhibitors treatment during early stages of MB differentiation. Upper 
panels: Brightfield images at day 11 of differentiation before MatrigelTM embedding. Small 
molecules treatment from day 0 (C2 and C3) generated neural tissues with a smoother shape 
compared to untreated (C1) and day 3 (C4) treatment conditions. Middle panels: At day 15 of 
differentiation, C2 and C3 neural tissues started to show sign of a hard pushing to neural fate. 
Lower panels: At day 28 of differentiation, C2 and C3 neural tissues were fully differentiated in 
the MatrigelTM droplets and was not possible to identify the organoid structure, while C1 and 
C4 neural tissue did.   
 
I tested four different treatment conditions (C1: untreated condition; C2: 
treatment from day 0 to day 3 with 10 M SB431542 and 1 M Dorsomorphin; 
C3: treatment from day 0 to day 6 with 10 M SB431542 and 1 M 
Dorsomorphin; C4: treatment from day 3 to day 6 with 10 M SB431542 and 1 
M Dorsomorphin).  
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Brightfield images at day 28 of differentiation showed that C2 and C3 
treatment conditions pushed the cells to a neural fate in such a way that it did not 
allow the formation of structures that resemble cerebral organoids. Instead, they 
formed 3D neuron cultures with visible signs of degradation. In contrast, C4 
treatment condition allowed the formation of MB (Fig. 3.5). 
Therefore, I excluded C2 and C3 conditions and proceeded with the C1 and C4 
treatment conditions for the following analysis. 
I tested the expression of early mesodermal (Brachyury) and endodermal 
(GATA4) markers in 5 MBs from two independent experiments harvested at 
three different time points (d11, d32 and d60) during differentiation. 
The two-way ANOVA analysis indicated that the difference in Brachyury and 
GATA4 genes expression between C1 and C4 harvested MBs was significant 
only at d11 of differentiation (Fig. 3.6). This is possibly due by the fact that the 
chosen genes are specific for early meso-endodermal differentiation. Therefore, 
I will perform gene expression analysis for mature meso-endodermal markers in 
order to confirm the efficacy of small molecules treatment also at later time points 
of MB differentiation. 
 
 Fig. 3.6 qPCR analysis for early mesodermal and endodermal markers. Two-way ANOVA 
followed by Sidak´s multiple comparisons test. ** for p < 0.005; **** for p < 0.0001. 
 
Nevertheless, the reduction of early meso-endodermal markers at d11 of 
differentiation was promising for the efficacy of the small molecules treatment 
over the possibility to standardize MB differentiation (Fig. 3.6). 
I continued to analyze the expression of neural differentiation markers in MB at 
five different time points (d11, d32, d60, d90 and d120) of differentiation.  
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Fig. 3.7 qPCR analysis for neural differentiation markers. Two-way ANOVA followed by 
Sidak´s multiple comparisons test. ** for p < 0.005; *** for p < 0.0005; **** for p < 0.0001 
 
I performed qPCR analysis for neural precursor markers (OTX1, PAX6 and 
BRN2) and mature neuron markers (MAP2, NCAM1 and SYN1) in 5 to 10 MBs 
from two independent experiments. The results showed that small molecules 
treatment induces an increase in neural precursor genes expression (OTX1, 
PAX6, BRN2; Fig. 3.7). The two-way ANOVA test confirmed the significance 
of the increased gene expression in C4-MBs especially at d11 and d32 of 
differentiation. On the other hand, small molecules treatment did not prompt any 
significant increase in mature neuron genes expression (MAP2, NCAM1, SYN1; 
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Fig. 3.7). Moreover, small molecule treatment did not improve the high 
variability in gene expression observed in MB generation. 
 
 
3.3.4 Minibrain as model system for Parkinson´s diseases 
 
One of the key pathological characteristics of most neurodegenerative 
diseases is the formation of insoluble protein aggregates that can spread 
throughout the brain. Protein aggregation and spreading is challenging to 
replicate in vitro, but it has been possible in several transgenic mouse models. 
However, the use of mouse models to find modifiers of the aggregation is very 
time consuming and expensive. 3D MBs might be used to assess the aggregation 
and spreading of insoluble aggregates in lines carrying mutations in genes 
implicated in neurodegenerative disease.  



 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.8 SNCA-RFP lentiviral vector map. mCherry-tagged SNCA gene is cloned under EF1 
constitutive promoter to lead a stable expression of SNCA protein. mCherry tag allows SNCA 
visualization via microscopy imaging and cell sorting via Fluorescence activated cell sorting 
(FACS). 

SNCA has been recognized as genetic risk factor for both Mendelian and 
sporadic forms of PD. -syn protein is the main component of Lewy bodies 
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aggregates and plays a central role in disease process. Nevertheless, the 
mechanisms that lead to -syn protein aggregation and toxicity are still unknown. 
In order to assess these mechanisms, I generated MB from a SNCA-
overexpressing iPS cell line. Brightfield images of SNCA overexpressing MB at 
various stages of differentiation showed that this mutant iPS cell line is able to 
generate MBs in culture (Fig. 3.9). Further, I analyzed the expression of neural 
differentiation markers to understand whether I could find differences between 
WT NAS6 and SNCA overexpressing MBs. I analyzed via qPCR the expression 
of neural precursor markers (OTX1, PAX6, BRN2) and mature neuron markers 
(MAP2, NCAM1) in 2 SNCA overexpressing MBs harvested from two 
independent experiments at three time points (d11, d32, d60) of differentiation 
and compared to 7 WT NAS6 MBs from three independent experiments.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.9 SNCA overexpressing NAS6 iPS-derived MB. Brightfield images of SNCA 
overexpressing MBs at various time points during differentiation. 
 
The analysis showed the same trend of gene expression in both WT NAS6 
and SNCA overexpressing MB during the differentiation. Moreover, high 
variability in gene expression was observed in SNCA overexpressing MBs as 
well (Fig. 3.10). Interestingly, qPCR analysis showed reduced level of the neural 
precursor/cortical marker BRN2 at d32 and d60 of differentiation in SNCA 
overexpressing MBs compared to WT NAS6 MBs (Fig. 3.10). Moreover, a 
reduction in mature neuron genes (MAP2, NCAM1) expression has been 
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observed in SNCA overexpressing MB at d60 of differentiation compared to 
aged-matched WT NAS6 MBs (Fig. 3.10).  
 
Fig. 3.10 qPCR analysis for neural differentiation markers in WT NAS6 and SNCA 
overexpressing NAS6 MBs. Two-way ANOVA followed by Sidak´s multiple comparisons test. 
* for p < 0.05; ** for p = 0.005; **** for p < 0.0001 
 
Despite the small number of MBs analyzed, the differences in neural markers 
gene expression between WT NAS6 and SNCA overexpressing MB are 
significant (BRN2, MAP2, NCAM1; Fig. 3.10). Further analysis will be 
performed with a larger number of MBs in order to confirm the observed results. 
On the other hand, immunostaining analysis for neural markers did not show 
clear structural differences between WT NAS6 and SNCA overexpressing MB 
(Fig. 3.11). Indeed, subventricular-like structures were clearly recognizable in 
SNCA overexpressing MB as well as in WT NAS6 MBs. Nevertheless, despite 
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that a quantitative estimation of neural populations has not been performed, 
PAX6+ and CTIP2+ cells were present in lower amount in SNCA overexpressing 
MB compared to WT NAS6 MB (Fig. 3.11) even though, BRN2 staining did not 
show big alteration neither in amount or localization of BRN2+ cells compared 
to WT NAS6 MB.  
 
Fig. 3.11 Immunostaining analysis WT NAS6 and SNCA overexpressing MBs at day 45 of 
differentiation. SNCA overexpressing MB (lower panels) contained less PAX6+ and CTIP2+ 
cells compared to WT NAS6 MBs (upper panels). No differences were observed in the amounts 
of BRN2+ cells between WT NAS6 and SNCA overexpressing MBs. mCherry fluorescence was 
poorly detected in SNCA overexpressing MBs (lower panels). Scale bars: 50 m. 
 
Moreover, the presence of mCherry-tag would have allowed to detect SNCA 
overexpressing cells in SNCA overexpressing MBs. mCherry fluorescence was 
not detectable in WT NAS6 MB and very few mCherry+ cells have been found 
in SNCA overexpressing MB (Fig. 3.11). qPCR analysis for SNCA expression 
in WT NAS6 MBs showed that SNCA started to be detectable at d32 of 
differentiation and increased at d60 of differentiation. On the other hand, as 
expected, SNCA expression in SNCA overexpressing MBs was greater than the 
age-matched WT counterpart at all the time points analyzed, although it 
decreased over the time (Fig. 3.10).  
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A possible explanation about these observations on SNCA in SNCA 
overexpressing MBs might arise by the fact that the starting SNCA 
overexpressing iPS cell line was a mixed population of cells containing different 
numbers of random integrations. During MB differentiation, processes such as 
proliferation, differentiation and apoptosis take place and it might be that some 
cells are more prone than others to die. In particular, the cells with the highest 
number of integrations could have died during differentiation, thus leaving only 
the cells carrying few integrations contributing to MB generation.  
mCherry-tag might be used to fluorescence activated cell (FAC)-sort SNCA 
overexpressing iPS cells according to the number of virus integrations thus 
generating at least three sub-populations (low, medium and high) of SNCA-
expressing cells. This might be a possible strategy to further characterize SNCA 
overexpressing MB and in particular to better understand the effect of SNCA 
overexpression in MB generation. 
 
 
3.3.5 Oxidative stress status in WT NAS6 and SNCA 
overexpressing Minibrain  
 
Oxidative stress is a well-known issue in neurodegenerative disease, 
including PD, in which it is thought to play an important role.  
Moreover, during last decade a possible interplay between SNCA expression 
and Nrf2/ARE antioxidant pathway has been proposed. Indeed, it has been shown 
that Nrf2 deletion in SNCA overexpressing mouse models for PD aggravates 
neurodegeneration (Lastres-Becker et al., 2012). Furthermore, the authors 
showed the activation of the Nrf2/ARE pathway in PD postmortem brain tissues. 
In particular, they observed an increase in astrocytic and microglia expression of 
HMOX1 suggesting a possible role for Nrf2 in counteracting -syn toxicity 
(Lastres-Becker et al., 2012).  
Nrf2/ARE pathway activation in astrocytes seems to be sufficient to protect 
against neurodegeneration in MPTP treated PD mouse models (Chen et al., 
2009). On the other hand, it has also been shown that MPTP treatment induced 
HMOX1 expression in Substantia nigra and ventral midbrain, suggesting that 
also neural Nrf2 activation might play an important role in -syn -mediated 
oxidative stress (Innamorato et al., 2010). 
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Fig 3.12 qPCR analysis for oxidative stress markers on WT NAS6 and SNCA 
overexpressing NAS6 MBs. Two-way ANOVA followed by Sidak´s multiple comparisons test. 
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* for p < 0.002; Two-way ANOVA followed by Turkey´s test. ## for p < 0.005; ### for p < 0.001.  
 
Indeed, HMOX1 has been shown to accumulate in postmortem PD brain 
(Schipper et al., 1998) especially in dopaminergic neurons of Substantia nigra 
pars compacta where it colocalized in Lewy bodies.  
The expression of HMOX1 and other Nrf2 regulated antioxidant genes, such 
as Glutathione synthetase (GSS) and Thioredoxin reductase 1 (TRDX1) was 
induced in mouse dopaminergic neurons upon stimulation with H2O2 (Yoo et al., 
2003). 
Likewise, studies performed in mouse models of PD showed the positive 
effect of Nrf2/ARE signaling pathway activation over the pathology progression 
(Lastres-Becker et al., 2016).  
Therefore, I analyzed the expression of three out of the hundreds Nrf2/ARE-
regulated antioxidant genes: HMOX1, TRDX1, SOD1 (also shown to colocalize 
in Lewy bodies (Nishiyama et al., 1995) and to physically interact with -syn 
protein both in vitro and in vivo (Helferich et al., 2015)). In particular, I measured 
their expression in SNCA overexpressing MBs from two independent 
experiments and compared this to WT NAS6 MBs gene expression at four time 
points (d11, d32, d60, d90) of differentiation. 
qPCR analysis showed a significant increase in HMOX1 gene expression at 
d90 of differentiation in both WT NAS6 and SNCA overexpressing MBs. 
Moreover, HMOX1 expression in d90 SNCA overexpressing MBs was increased 
compared to aged-matched WT NAS6 MBs (Fig 3.12). On the other hand, no 
significant differences were observed in the expression of SOD1 and TRDX1 
between WT NAS6 and SNCA overexpressing MBs at any of the time points 
analyzed. Nevertheless, SOD1 expression increased in d90 WT NAS6 MBs (Fig 
3.12). 
 
 
3.4 CONCLUSIONS 
 
3D cerebral organoids are emerging as a very promising tool to model and 
study human brain development and diseases. Nevertheless, this new technology 
still needs to be improved in terms of stability and reproducibility of the 
generated 3D cultures. 
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I generated MBs from a WT hiPS cell line in order to characterize their 
differentiation and growth. Seeding density condition is considered a crucial 
factor that may influence neural differentiation in 2D cultures and this may affect 
3D culture as well. 
Therefore, I tested three seeding conditions and found the best among those 
for the WT NAS6 iPS cell line and performed the characterization at gene 
expression level, using a set of markers to assess neural differentiation. From the 
gene expression analysis via qPCR I showed the general process of 
differentiation. MBs up to one month of differentiation were still immature as 
they expressed high levels of neural precursor markers (Fig 3.2). After two 
months in culture they started to be more differentiated as shown by the 
expression of mature neuron markers (Fig 3.3). Moreover, at d60 of 
differentiation MBs started to exhibit signs of neural maturation. For example, 
SYN1 gene expression is normally associated with the presence of mature 
neurons characterized by firing potential. SYN1 expression started to be 
significantly detectable at d60 of MB differentiation and increased at the later 
time point (d90) analyzed (Fig 3.3). 
In parallel to the characterization at the gene expression level, I performed 
immunostaining analysis. This analysis allowed visualizing the internal 
organization of MB and showed that MBs contain structures that resemble those 
of the human brain, such as the subventricular zone. Inside these subventricular-
like structures cell populations organized in layers suggestive of the concomitant 
differentiation and migration of neural cells through the layers (Fig 3.4) in a 
fashion similar to that observed in vivo. 
One of the main limitations of this system is the high variability that 
characterizes MBs generation. This is possibly due to the minimal induction to 
neural fate that relies on the assumption that stem cell differentiation in absence 
of external stimuli follows the default neural pathway. The presence of 
mesodermal cells, however, indicated that not all the cells follow the neural 
differentiation pathway (Quadrato et al., 2017). On the contrary, some of them 
seem to escape the default neural differentiation and get specified for meso-
endodermal lineages. Treatment from day 3 of differentiation with SMAD 
inhibitors revealed to be useful to reduce the amount of meso-endodermal 
population in MBs as shown by the expression analysis of early mesodermal and 
endodermal markers that were strongly reduced at d11 time point of 
differentiation (Fig. 3.5). However, the treatment did not result in a robust 
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improvement of the differentiation protocol. MBs derived using small molecules 
treatment condition still exhibited high gene expression variability, as emerged 
by the qPCR analysis for neural differentiation markers at various time points 
during differentiation. Therefore, other strategies need to be taken into account 
in order to make MB generation more stable and reproducible.  
A possible route might be to synchronize the iPS cell cycle before seeding.  
Cells in culture may reside in different stages of cell cycle progression. 
Therefore, some cells might be more prone than others to move toward an 
asymmetric division instead of the symmetric one that characterizes non-
differentiating/proliferating stem cells. Synchronized cells, instead, are all in the 
same stage of cell cycle progression and should all react the same way when 
induced to differentiate. 
Synchronized iPS cells can be obtained via treatment with a microtubule 
destabilizer agent, such as Nocodazole (Yang et al., 2016). This agent interferes 
with microtubule polymerization and cause arrest in the G2/M phase of the cell 
cycle. Thus, cell-cycle synchronization might reduce the propensity of the cells 
toward a cell division rather than another and maybe contribute to reduce MBs 
variability.  
I generated MBs from an iPS cell line that constitutively overexpresses 
SNCA gene thus mimicking the effect of the SNCA gene triplication that can 
cause a familiar form of PD. The SNCA overexpressing iPS cell line was able to 
generate MBs in culture even though qPCR analysis showed reduced levels of 
mature neuron markers at d32 and d60 of differentiation compared to WT NAS6 
MBs (Fig 3.10). However, no significant differences were observed in neural 
precursor markers expression (Fig 3.10). Alterations in SNCA overexpressing 
MB differentiation were also observed through immunostaining analysis, despite 
no structural differences have been seen in SNCA overexpressing MB compared 
to WT NAS6 MB.  These results suggest a possible impairment of the 
differentiation of SNCA overexpressing MBs that might involve the later stages 
of differentiation rather than the early one.  
The analysis of oxidative stress markers showed an increase in HMOX1 
expression over the time of differentiation. Moreover, SNCA overexpressing 
MBs exhibited higher level of HMOX1 mRNA at d90 of differentiation 
compared to WT NAS6 MBs (Fig 3.12). On the other hand, TRDX1 and SOD1 
expression did not show any significant difference between WT NAS6 and 
SNCA overexpressing NAS6 MBs. However, this analysis has been performed 
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in not stress-induced conditions where MBs were cultured in antioxidant 
containing medium that might hide possible differences in oxidative state. 
Therefore, it might be important to perform experiments in which oxidative stress 
is actively induced either via antioxidant depletion or via treatment with oxidant 
agents.  
In line with previous studies (Lastres-Becker et al., 2012), these results on 
HMOX1 expression suggest an interplay between -syn and Nrf2/ARE pathway. 
Several evidences indicated that mutations in SNCA gene trigger oxidative stress 
and mitochondrial damage (Junn and Mouradian, 2002; Martin et al., 2006; 
Shavali et al., 2008). Mitochondria are often impaired in neurodegenerative 
diseases (Gan et al., 2018) and the activation of Nrf2 pathway has been shown to 
rescue the -syn induced oxidative stress-mediated mitochondrial energy 
metabolisms impairment (Fu et al., 2018). Several evidences support the role of 
Nrf2 in maintenance of mitochondrial homeostasis and structure. Impairment in 
mitochondrial complex 1 activity has been observed in Nrf2 Knock-out (Nfr2-
KO; Kovac et al., 2015) and the mitochondrial protein DJ1, known to maintain 
the normal activity of mitochondrial complex 1 and known genetic risk factor for 
PD (Bonifati et al., 2003; Símon-Sáncez et al., 2009), has been shown to stabilize 
Nrf2 (Clements et al., 2006) although the molecular mechanisms are still poorly 
understood (Dinkova-Kostova et al., 2015) 
Therefore, mitochondria might be the missing link between SNCA 
overexpression and Nrf2 pathway activation. It might be interesting to measure 
the ROS production and ATP synthesis rate to evaluate the mitochondrial activity 
in SNCA overexpressing MBs. Furthermore, lentiviral transfection of SNCA 
overexpressing MBs with Nrf2 short hairpin RNA (shRNA), in order to mediate 
the pathway inactivation, might be helpful to understand the role of Nrf2/ARE 
pathway on mitochondrial homeostasis in SNCA overexpressing MBs. 
Thus, even though an effort still needs to be done in order to improve the 
stability and robustness of differentiation protocol, all together these results 
encourage the use of 3D MB culture to study human brain development and 
disease. Moreover, despite the limitations of this model system, it has emerged 
and reinforced the great potential of MBs also to model some aspects of 
neurodegenerative disease, such as PD.  
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Chapter 4 
 
DISCUSSION 
 
 
 
Neurodegenerative diseases such as PD, AD, HD and FTD are usually late-
onset and share many common altered mechanisms such as protein aggregation, 
synaptic dysfunction, decreased autophagy/lysosomal proteolysis, mitochondrial 
dysfunction and oxidative stress (Gan et al., 2018). These alterations are often 
interconnected. For example, decreased autophagic activity may lead to increased 
ROS production via mitochondrial turnover impairment. The link between 
autophagy and oxidative stress has been suggested in the pathophysiology of PD 
(Nakanishi et al., 2001; Giordano et al., 2014) and the activation of autophagy 
has been hypothesized to be beneficial for the reduction of oxidative stress 
propagation and to delay neurodegeneration (Giordano et al., 2014). There are 
numerous evidences that highlight the causative role of oxidative stress in 
neurodegenerative diseases (Okun et al., 2007; Sanders et al., 2013; Kouti et al., 
2013; Popa-Wagner et al., 2013) and antioxidant-based drugs have been 
considered for therapeutic applications in the treatment of neurodegenerative 
diseases (Liu et al., 2017). However, there are still open questions, about the main 
oxidant molecules involved and how these oxidants affect the molecular 
mechanisms altered in neurodegenerative diseases, that need to be answered in 
order to identify potential antioxidant agents for the treatment of these 
pathologies (Patel, 2016). Oxidative stress has also been observed in 
developmental and childhood-onset brain diseases (Hayashi et al., 2012; Dasuri 
et al., 2013; Gan et al., 2018) such as in RTT (Filosa et al., 2015). A whole exome 
sequencing study revealed that mutations in MeCP2 protein gene correlate with 
variants in genes related to oxidative stress (Grillo et al., 2013). Moreover, 
MeCP2 regulates the expression of oxidative stress related genes, including those 
associated to ATP synthesis and mitochondrial functioning (Pecorelli et al., 
2013), suggesting a possible role of mitochondria in redox impairment observed 
in RTT patients. Since mitochondria are the major sources of ROS, an 
impairment in their normal functioning can result in oxidative burden. Of note, 
treatments directed to rescue systemic oxidative stress, such as -3 
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polyunsaturated fatty acids (-3 PUFAs), Trolox and Curcumin, showed a 
general amelioration of neural symptoms (De Felice, et al., 2012; Filosa et al., 
2015). To date, many mouse models have been generated in order to better 
understand the molecular mechanisms altered in Rett syndrome and to find the 
correlation between oxidative stress and MeCP2 depletion (Filosa et al., 2015). 
These models allowed to reproduce many of the alterations observed in RTT 
patients, including the systemic oxidative stress. They also provided the 
opportunity to hypothesize that redox imbalance and oxidative damage might 
precede the onset of symptoms. Moreover, MeCP2 reactivation in mice rescues 
the redox imbalance, thus giving strength to the possible role of MeCP2 protein 
in cellular response regulation against oxidative stress (De Felice et al., 2014). 
However, animal models are far to faithfully model the human pathologies 
and the current human diseases research is facing the limitations that the existing 
model systems present. Animal models, especially rodents, offer great 
possibilities in term of genetic engineer potentials and they allow studying 
biological processes in fully developed organs in vivo. However, the differences 
between rodents and human species might be relevant when studying aspects of 
human development and diseases. Moreover, their use in research is challenging 
due to cost expensiveness and ethical issues. 
The introduction of stem cells represent a breakthrough in human diseases 
research. ES cells have been isolated for the first time from mouse embryos in 
1980s (Evans et al., 1981; Martin, 1981) and from donated human embryos in 
1998 (Thomson et al., 1998). Since then, ES cells have constituted an important 
tool for genetic engineering and a valuable model system for basic research on 
pluripotency and developmental biology as well as for biomedical research. The 
availability of a wide range of differentiation protocols allows to study the 
molecular mechanisms that drive cell differentiation and take place during 
development. Moreover, ES-derivatives have been used in preclinical studies as 
potential therapeutic strategies for spinal cord injury (Hans S. Keirstead et al., 
2005), eye-diseases (Lu et al., 2009), infarct-injured hearts (Shiba et al., 2012), 
diabetes (Pagliuca et al., 2014), PD (Ambasudhan et al., 2014), cancers and 
immunological diseases (Chivu-Economescu and Rubach, 2017). The 
introduction of human patient derived-iPS cells (Takahashi et al, 2007) opened 
the way for new opportunities in regenerative medicine. Patient derived-iPS cells, 
indeed, maintain the genetic background of the donor patient and are more 
suitable than human ES cells for transplantation because they avoid immune 
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rejection issues (Soldner and Jaenisch, 2018). Upon gene correction, iPS cells 
can be differentiated into, ideally, all the cell types of the body making it feasible 
to reintroduce the specific cell types that have been lost during the progression 
of a specific diseases, such as the dopaminergic neurons in PD patients (Trounson 
and DeWitt, 2016). Beside that, stem cells represent a powerful model system to 
study human diseases. Indeed, by taking advantage from mutant ES cell lines or 
patient-derived iPS cells, it is possible to investigate on those mechanisms that 
have been altered in specific cell types during pathologies (Soldner and Jaenisch, 
2018). Furthermore, one of the major advantages of stem cell technology is the 
possibility to perform high throughput screenings in order to test the effectiveness 
of drugs and compounds on a disease-associated phenotype for therapeutical 
applications (Soldner and Jaenisch, 2018).  
More recently, the introduction of 3D cultures offered a straightforward 
opportunity to recreate and study a plethora of phenomena in complex in vitro 
systems. Stem cell-derived 3D cultures resemble better than 2D systems the 
microenvironment needed for cell differentiation, thus offering major reliability 
than 2D cultures for human developmental studies. Given their complexity, in 
which several human brain-like structures grow and connect among each other, 
3D Minibrains represent an unprecedented tool to study in vitro some 
mechanisms of neurological diseases progression that were not possible to 
investigate in 2D systems and would have required the use of animal models. 
Moreover, since they are in vitro systems, 3D cultures retain the scalability 
potential that would apply to high-throughput strategies for drug screening. Even 
though an effort still needs to be done in order to make Minibrain generation 
more complete and reproducible, 3D Minibrains offer the opportunity to fill the 
gap existing between in vivo animal models and in vitro human 2D systems.  
The use of ES and iPS cells and the possibility to differentiate them into 
complex 3D organoids is promising to move forward in the comprehension of 
human brain diseases and, hopefully, shorten the way for therapeutic strategies 
that might at least improve the lifespan and life quality of Rett disease patients, 
as well as for neurodegenerative diseases. 
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The protective effects of ethanolic olive fruit extract (OFE) and purified oleuropein (Ole) have been eval-
uated against H2O2-induced oxidative damage and apoptosis in human embryonic kidney (HEK-293)
cells. Olive compounds demonstrated a protective effect against H2O2-induced cell death resulting in
total rescue of cell viability. This effect was accompanied by a marked decrease in intracellular reactive
oxygen species (ROS) and lipid peroxidation as evidenced by malondialdehyde (MDA) production.
Consequently, olive compounds reduced the apoptotic cell death. This was confirmed by flow cytometry
analysis for multicaspases and by western blot and real-time PCR analyses for the expression of key effec-
tors involved in the apoptotic process. Our data suggest that the anti-apoptotic effect could be due to the
activation of the Erk/p38 signaling pathway and to the modulation of Bcl-2/Bax ratio. These findings pro-
vide new insight into the mechanisms underlying the protective effects of OFE and Ole against oxidative
damage-induced apoptosis.
 2017 Elsevier Ltd. All rights reserved.1. Introduction
Reactive oxygen species (ROS) resulting from oxidative stress
are unstable and can damage vital components of the cell leading
to alterations in cell membrane fluidity, permeability as well as
DNA breakdown (Fernández-Blanco, Font, & Ruiz, 2015). It is well
known that hydrogen peroxide (H2O2) is one of the strongest oxi-
dants triggering, both in vivo and in vitro, ROS accumulation (Frei &
Higdon, 2003; Liu et al., 2014). Oxidative stress is responsible for
renal diseases, ranging from acute (Baliga, Ueda, Walker, & Shah,
1999) to chronic renal failure with associated inflammation
(Handelman et al., 2001). However, the protective effect of antiox-
idants against such diseases has been poorly analyzed (Rodrigo &
Bosco, 2006). In addition, contrast media induced nephropathy,
are known to be a serious complication of radio diagnostic proce-
dures. In fact, contrast media exposure significantly increases the
oxidative stress in kidney, resulting in an increase in TBARS and
decrease in GSH. Many attempts have been made to select antiox-idant molecules able to protect the kidney from this damage
(Sterling, Tehrani, & Rudnick, 2008).
It has been reported that some phenolic compounds contribute
to modulating the systemic antioxidant defense through enhanc-
ing the plasma antioxidant capacity in humans (Carrizzo et al.,
2013; Duthie et al., 1998).
Mitochondria being one of the major sources of ROS are associ-
ated with an important signaling pathway in apoptosis (Crispo
et al., 2010). The main events involved in this pathway are the
release of cytochrome c and the decrease of mitochondrial mem-
brane potential. Thereby, the activation of caspases and Bcl-2 takes
place (Tang & Tai, 2007). It has been reported that oxidants can
trigger the activation of numerous signaling pathways including
MAPK (mitogen-activated protein kinases) (Martindale &
Holbrook, 2002). These proteins are made of three major subfami-
lies that have structural differences: Erk (the extracellular signal-
regulated kinase), p38 kinase and JNK (the c-Jun N-terminal
kinase). Such kinases are activated by phosphorylation of both
threonine and tyrosine residues. Activated MAPK phosphorylate
their specific substrates on threonine and/or serine residues lead-
ing to the activation of several transcription factors (Park, Yoo,
Kim, Kwon, & Kim, 2005). Furthermore, the p38 pathway has been
A. Maalej et al. / Journal of Functional Foods 39 (2017) 18–27 19associated with cell growth and differentiation, cytokines produc-
tion, inflammation, and cell death (Rodríguez-González, Wilkins-
Rodríguez, Argueta-Donohué, Aguirre-García, & Gutiérrez-Kobeh,
2016). On this line, experimental studies on animals or cultured
human cell lines showed that olive compounds protect against
the development of chronic diseases such as cancers, diabetes
and cardiovascular diseases through different pathways. Recent
study demonstrated the anticancer potentiel of an olive fruit
extract against hepatic HepG2 and colon Caco-2 cancer cells. In
fact, this polyphenols-rich extract decreased cell viability, inhib-
ited cell proliferation and induced cell apoptosis through the Akt
and MAPKs/Erk pathways (Maalej, Bouallagui, Hadrich, Isoda, &
Sayadi, 2017). Similar effects were observed in human breast can-
cer MCF-7 cells treated with oleuropein or hydroxytyrosol (Han,
Talorete, Yamada, & Isoda, 2009). On the other hand, some investi-
gators reported that phenolic compounds with high reducing abil-
ity can be not only antioxidants but also pro-oxidants, thus
generating reactive oxygen species (ROS) (Lopaczynski & Zeisel,
2001). This could be the possible mechanism of action of antioxi-
dants for tumor suppressive effect (Han et al., 2009). ROS may even
activate apoptotic death pathways. In addition, polyphenols can
prevent tumor invasion via inhibition of the matrix metallopro-
teinases (Maeda-Yamamoto et al., 1999). Hadrich, Mahmoudi,
et al. (2016) reported the anti-obesity effects of oleuropein,
in vivo, by increasing adiponectin levels in serum, modulating
lipids metabolism and activating AMPK in white adipose tissue in
high cholesterol diet-induced obese rat. Hadrich, Garcia, et al.
(2016) also suggested that oleuropein plays a beneficial role in glu-
cose metabolism of differentiated C2C12 skeletal muscle cells sup-
porting the therapeutic potential of oleuropein to the treatment of
diabetes. More interestingly, antioxidant, antiapoptotic and anti-
inflammatory effects were also observed with olive fruit extract
and oleuropein administered orally to deltamethrin-induced liver
and kidney toxicity rats model (Maalej, Mahmoudi, et al., 2017).
However, the effect of olive compounds on H2O2-induced oxidative
injury on kidney cells is still poorly studied. The aim of the present
study was to evaluate the protective effect of a Tunisian olive fruit
extract (Jerboui fruit extract (OFE)), and purified oleuropein (Ole)
against H2O2-induced cell damage in human embryonic kidney
cells HEK-293. Even though this investigation did not show effects
on metabolic parameters in renal cells, more attention was paid to
study the mechanism underlying the potential protective effect of
olive compounds through monitoring their effect on the oxidative
status, as well as apoptotic proteins and genes expression.2. Material and methods
2.1. Preparation of olive fruit extract and purified oleuropein
Olive fruit from Jerboui cultivar grown in Béja prefecture (Tuni-
sia) was used to prepare extract. Fresh fruits (200 g) with a matu-
ration index of 2 were collected, manually milled, and extracted
twice with 350 mL of ethanol (70%) under agitation (200 rpm in
an orbital shaker) for overnight at room temperature. The extract
was concentrated and washed with hexane to remove the lipid
fraction. The resulting extract (OFE) was freeze-dried and stored
for further analyses. Oleuropein purification was performed as pre-
viously reported by our group (Hadrich, Mahmoudi, et al., 2016).
Briefly, 100 g of dried olive leaves were soaked in 500 mL distilled
water, stirred at room temperature overnight and filtered. The
resulting aqueous phase was then extracted thrice with equal vol-
ume of ethyl acetate. The organic phase was dried under vacuum
and the residue was chromatographed on silica gel at low pressure
using a mixture of methylene chloride and methanol. Finally, the
purified fraction was freeze-dried and stored until use.2.2. Phenolic characterization of olive compounds
A high-performance liquid chromatography analysis was devel-
oped to identify and quantify the major phenolic compounds of the
prepared OFE. The phenolic profile of OFE was obtained using an
Agilent series 1260 HPLC-DAD instrument (Agilent Technologies,
Waldbronn, Germany) following the method previously reported
by Souilem et al. (2014). The separation was carried out on a Zor-
bax Eclipse XDB-C18 column (4.6 mm I.D.  250 mm  3.5 lm
particle size). The mobile phase was 0.1% acetic acid in water (A)
versus 100% acetonitrile (B) for a total running time of 50 min.
The elution conditions applied for phenolic compounds were: 0–
22 min, 10–50% B; 22–32 min, 50–100% B; 32–40 min, 100% B;
40–44 min, 100–10% B. The column was subjected to washing
and reconditioning step after each analysis using 100% acetonitrile.
The column temperature was maintained at 40 C and the flow rate
of the mobile phase was 0.5 mL/min. The injection volume of the
OFE sample was 10 lL. Detection was performed using a diode
array detector (DAD), and the chromatograms were recorded at
k = 254 nm for oleuropein and at 330 nm for flavonoids (Luteolin
glucoside, apigenin glucoside and verbascoside). Quantification
was performed using external standards (oleuropein, luteolin glu-
coside, apigenin glucoside, verbascoside, gallic acid, hydroxyty-
rosol, tyrosol, caffeic acid, rutin, p-Coumaric, ferulic acid, and
quercetin) from Sigma-Aldrich.
2.3. Cell culture
Human embryonic kidney cells (HEK-293) (CRL-1573, American
Type Culture Collection, Manassan, VA) were cultured in Dul-
becco’s modified Eagle medium (DMEM) supplemented with 10%
dextran-coated charcoal fetal bovine serum (FBS) and 1% peni-
cillin/streptomycin solution and maintained at 37 C under 5%
CO2 and 95% air. When confluent, cells were detached enzymati-
cally with trypsin-ethylenediamine tetra-acetic acid (Trypsin-
EDTA) and sub-cultured into a new cell culture flask. The medium
was replaced every 2 days.
2.4. Cell viability analysis
Cell viability was analyzed by measuring the conversion of MTT
into the purple formazan, a property distinctive of cells with active
metabolism. Cells were seeded in 96-well plates at a density of 3 
104 cells/well and incubated overnight. The plates were treated
with olive compounds OFE (50–200 mg/mL) and Ole (10–50 mg/m
L) for 18 h. Then, cells were exposed to 400 mM H2O2 for 6 h as
reported in the appropriate sections. Next, the medium was
removed, 100 mL new medium and 10 mL MTT solution (5 mg/mL)
were added and incubated at 37 C for 4 h. Finally, 100 mL SDS
(10%) was used in order to dissolve the formazan crystals. The opti-
cal density (OD) was measured at 570 nm using a microplate
reader (Thermo Scientific Varioskan Flash).
2.5. Clonogenic assay
Clonogenic assay (colony formation assay) is an in vitro cell sur-
vival assay based on the ability of a single cell to grow into a colony
(at least 50 cells) (Rafehi et al., 2011).
HEK-293 cells (1  105 cells/well) were plated in 10-cm diame-
ter Petri dishes and incubated for 24 h at 37 C to attach before
treatment with OFE or Ole for 18 h. After further incubation for
6 h in the presence of H2O2 (400 mM), the cell suspension was
diluted 1:1000 and seeded into 10-cm diameter Petri dishes for
clonogenic assay according to the method previously described
by Franken, Rodermond, Stap, Haveman, and Van Bree (2006). Petri
dishes were placed in a 5% CO2 incubator until control cells have
Table 1
Primer sequences for qPCR amplification.
Gene Primer sequence
Sirt 1 Forward TGTACGACGAAGACGACGAC
Reverse TTCATCACCGAACAGAAGGTT
Ask 1 Forward CCAGGGCCTCTTCCTGCTA
Reverse TCTGCTCCTCCCAGAGGATTT
GAPDH Forward CAAGGCTGTGGGCAAGGT
Reverse GGAAGGCCATGCCAGTGA
20 A. Maalej et al. / Journal of Functional Foods 39 (2017) 18–27formed large clones (one week). Colonies were then fixed with glu-
taraldehyde (6.0%, v/v) and stained with crystal violet (0.5%, w/v).
2.6. TBARS assay
Thiobarbituric acid-reactive substances (TBARS) are markers of
lipid peroxidation. We measured their concentrations using the
method described by Fki, Sahnoun, and Sayadi (2007) with slight
modifications. Briefly, HEK-293 cells were seeded in a 24-well
plate at a density of 1.0  105 cells/well and cultivated at 37 C in
5% CO2 for 24 h. Plates were pre-treated with various concentra-
tions of studied samples for 18 h before exposure to 400 lM of
H2O2 for additional 6 h. Cells were lysed using RIPA buffer (BioBa-
sicInc, Canada) and centrifuged at 3000 rpm for 10 min. The pellet
was then resuspended in 500 lL of deionized water and 1 mL of
TBA solution (15% trichloroacetic acid, 0.8% thiobarbituric acid,
0.25 N HCl) was added. The mixture was incubated at 95 C for
15 min. After cooling to room temperature, optical density was
measured at 532 nm. Values were reported to a calibration curve
prepared with 1,1,3,3-tetraethoxypropane (TEP).
2.7. Measurement of intracellular ROS
Intracellular reactive oxygen species (ROS) production was
measured using DCFH-DA as previously mentioned by Lou, Jing,
Ren, Wei, and Zhang (2012) with slight modifications. In a 24-
well plate, 105 cells/well were exposed to OFE or Ole pretreatment
for 18 h and then incubated with 400 mM of H2O2 for 6 h. Cells
were then incubated with 20 lM of DCFH-DA for 30 min. Then,
cells were rinsed three times with PBS, trypsinized and collected
by centrifugation (1000 rpm for 5 min). 200 mL of PBS solution con-
taining 30.000 cells were transferred to a 96-well microplate. The
fluorescence intensity was detected using the excitation/emission
couple 488/525 nm.
2.8. Flow cytometry analysis of apoptotic cells
In order to evaluate the apoptotic rate of HEK-293 cells, multi-
caspases assay was performed. Cells were seeded in Petri dishes
and treated with different concentrations of OFE (100 and 200
mg/mL) or Ole (25 and 50 mg/mL). Cells were then collected, washed
twice with PBS, and stained with SR-VAD-FMK (sulforhodamine-
valyl-alanyl-aspartyl-fluoromethylketone) and 7-amino-
actinomycin D (7-AAD) following the manufacturer instructions
(Cat. No. 4500–0530, EMD Millipore Corporation, Hayward, CA
94545). Apoptotic cell populations were quantified using Guava
PCA system (Guava Technologies).
2.9. Western blot analysis
Protein extraction was performed after cell treatment by means
of ice-cold RIPA buffer (Bio Basic Inc., Canada), supplemented with
protease inhibitor cocktail (Roche Life science, Germany) for 5 min
followed by centrifugation (12.000g) for 10 min at 4 C. Total pro-
tein concentration was determined using the Bradford reagent. The
expression of target proteins; Bax, Bcl-2, p21, p38, P-Erk, Erk, P-
Akt, Akt, Cox-2 and b-actin, was determined by western blot anal-
ysis using monoclonal antibodies (Cell Signaling Technology, Dan-
vers, MA USA). Briefly, for each sample 30 mg proteins were
separated on SDS–polyacrylamide gel and transferred to
polyvinylidene fluoride membranes. The membranes were blocked
with 5% non-fat dry milk in TBS (Tris-buffered saline) with 0.1%
Tween 20 (TBS-T) for 30 min at room temperature and incubated
overnight at 4 C with primary antibodies. Antibodies were
detected using the HRP-conjugated secondary antibody for 1 h at
room temperature. b-actin was used to normalize the amount ofloaded proteins. Immunoreactive bands were visualized using
enhanced chemiluminescence reagents (ECL) and densitometric
analysis was performed using ‘‘Image J” image analysis software.
The experiments were performed in triplicates.2.10. RNA extraction and qPCR analysis
Total RNA from HEK-293 cells treated with OFE or Ole were
extracted using Trizol (Life Technologies). DNA residues were
removed using DNAseI (Life Technologies) and RNA was quantified
using Experion system (BioRad). For qPCR assays, 200 ng of RNA
from each sample were retro-transcribed using the High Capacity
c-DNA Reverse Transcription Kit (Applied Biosystems) following
manufacturer instructions. Q-PCR was performed using a 7900 HT
Real Time PCR (Life Technologies) and SYBR Select Master Mix 2X
assay (Applied Biosystems, Foster City, CA, USA). All primers were
designed using the Primer Express 3.0 software (Applied Biosys-
tems) (Table 1). The amount of c-DNA target was calculated using
the average value of the DCT between the target and the control
(GADPH) gene, and was expressed as 2DDCT (Livak & Schmittgen,
2001), where DDCT = (CTTarget  CTGADPH)Treatment  (CTTarget 
CTGADPH)Control. Three separate experiments (n = 3) were performed
for qPCR and each sample was tested in triplicate in an individual
run.2.11. Statistical analysis
All experiments were conducted with three independent exper-
iments, and values were expressed as means ± standard deviation
(SD). The data were statistically analyzed by one-way ANOVA,
using Tukey’s multiple comparisons test and applying a signifi-
cance level of p  0.05.3. Results
3.1. Compositional characterization of OFE and Ole
Using HPLC analysis, it was possible to reveal the presence of
several phenolic compounds the chromatograms were recorded
at k = 254 nm for oleuropein, and at 330 nm for flavonoids (verbas-
coside, luteolin glucoside and apigenin glucoside). HPLC chro-
matograms of the OFE (Olive fruit extract) and Ole (purified
oleuropein) are depicted in Fig. 1. Peaks were identified by com-
paring of the retention time and UV spectra of olive compounds
with those of standards in the same conditions. Oleuropein
(18.93 min) was the major phenolic compounds identified in OFE
(Fig. 1A) while verbascoside (15.29 min), luteolin glucoside
(15.76 min), and apigenin glucoside (17.46 min), were the three
main flavonoids (Fig. 1B). The chromatogram of Fig. 1C depicts a
sharp monomodal peak of oleuropein at a retention time of
18.93 min. Oleuropein purity, determined by LC-MS-MS, was 98%.
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Fig. 1. HPLC chromatograms of olive fruit extract (A: k = 254 nm, B: k = 330 nm) and purified oleuropein (C: k = 254 nm). The chromatograms were recorded at k = 254 nm for
oleuropein (18.93 min) and at 330 nm for flavonoids: verbascoside (15.29 min), Luteolin glucoside (15.76 min) and apigenin glucoside (17.46 min).
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and proliferation of HEK-293 cells
To determine the adequate concentrations of OFE and Ole to be
used in the experiments, HEK-293 cells were incubated with differ-
ent concentrations of OFE and Ole for 24 h. The results indicated
that low concentrations of both OFE (e.g., 50, 100, 200 lg/mL)
and Ole (e.g., 10, 25, 50 lg/mL) did not show any toxic effect (data
not shown).
Treatment with H2O2 at the concentration of 400 mM was
shown to have a significant toxic effect (45.35% ± 2.08) after 6 h
of exposure.
For combined treatments, cells were pre-incubated with OFE
(50, 100 and 200 lg/mL) or Ole (10, 25 and 50 mg/mL) for 18 h then
treated with 400 lM of H2O2 for additional 6 h. As shown in
Fig. 2A, OFE at doses 100 and 200 lg/mL strongly prevented
H2O2-induced toxicity while there was a moderate effect at 50
lg/mL. Similarly, a protective effect was also exhibited by Ole
treatment at concentrations of 10, 25 and 50 mg/mL.
Cells proliferation was further evaluated by clonogenic assay
(Fig. 2B). The colony-forming efficiency was significantly restored
in cells pretreated with OFE or Ole than in H2O2-treated cells.
Therefore, the two highest protective concentrations of OFE (100
and 200 mg/mL) and Ole (25 and 50 mg/mL) were selected for use
in further experiments.3.3. OFE and Ole protect cells from ROS generation and lipid
peroxidation
ROS and TBARS assays were carried out for monitoring reactive
oxygen species and lipid peroxidation generation as the major
index of oxidative stress. As shown in Fig. 3A and B, exposure of
HEK-293 cells to H2O2 led to an increase in both ROS and TBARS
levels in comparison to the control cells.
Interestingly, both OFE (100 and 200 mg/mL) and Ole (25 and 50
mg/mL) significantly reduced H2O2-induced ROS and TBARS forma-
tion in a dose-dependent manner (Fig. 3A and B).3.4. OFE and Ole reduce H2O2-induced apoptosis
To elucidate whether the observed reduction in cell viability
induced by H2O2 treatment was associated with apoptosis, we
examined the apoptotic cell populations using multicaspases assay
by means of flow cytometry. As expected, results showed an
increase of apoptotic cells after H2O2 exposure (46.16% (± 2.97);
P < .01). On the contrary, OFE (200 mg/mL) and oleuropein (50 mg/
mL) pretreatments strongly decreased the number of apoptotic
cells up to 6.18% (± 1.03) and 6.66% (± 2.06) (P < .01), respectively
(Fig. 4). Interestingly, no significant difference was detected
between cells treated with 200 mg/mL of OFE and those treated
with 50 mg/mL of Ole.3.5. Reduction of H2O2-induced apoptosis through the intrinsic
pathway
As described above, OFE at 200 mg/mL and Ole at 50 mg/mL
exerted the most significant protective effects on H2O2-induced
oxidative damage. Hence, these concentrations were used for fur-
ther experiments.
To examine the effectiveness of OFE and Ole in attenuating
H2O2-induced apoptosis, we analyzed Bax and Bcl-2 proteins
expression by western blotting analysis, since the ratio Bax/Bcl-2
is known to increase in apoptosis. HEK-293 cells were exposed to
H2O2 alone (400 mM for 6 h) or to H2O2/OFE and to H2O2/Ole. As
shown in Fig. 5 (A, C), Bax/Bcl-2 levels increased in cells exposed
to H2O2 compared to untreated cells. On the contrary, treatment
for 18 h with OFE (200 mg/mL) or Ole (50 mg/mL) markedly reduced
the Bax/Bcl-2 ratio.
Parallely, western blotting with a monoclonal antibody against
p21 protein level was performed and indicated a significant (P <
.01) increase in the protein expression in response to H2O2 treat-
ment (400 mM, 30 min) (Fig. 5B, D). This increase was strongly
inhibited after OFE (200 mg/mL, 24 h) or Ole (50 mg/mL, 24 h) pre-
treatment.
Fig. 2. Effect of OFE and Ole on H2O2-induced decrease in HEK-293 cell viability. Cells were pretreated with OFE (50–200 mg/mL) or Ole (10–50 mg/mL) for 18 h and then
exposed to H2O2 (400 mM) for 6 h. After the treatment, cell viability was determined using MTT assay (A) and cell proliferation was analyzed by clonogenic assay (B). Ctrl:
untreated cells or control. Data are expressed by means ± SD (n = 3). * Results were compared to control cells (p < .001). # Results were compared to H2O2-treated cells with
alone (p < .001).
Fig. 3. Protective effect of OFE and Ole on intracellular ROS (A) and lipid peroxidation (B) in HEK-293 cells. Cells were incubated with OFE (100 and 200 mg/mL) or Ole (25 and
50 mg/mL) for 18 h and then exposed to 400 mM of H2O2 for 6 h. Ctrl: untreated cells. Values are presented by means ± SD (n = 3). *** p < .001 compared to control cells and
### p < .001; ## p < .01; # p < .01 compared to H2O2-treated cells.
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protective function of Bcl-2, this result indicates that p21 could
promote H2O2-induced apoptosis modulating the molecular ratio
of Bcl-2/Bax in HEK-293 cells.
3.6. OFE and Ole attenuate P-p38 and P-Erk MAPK proteins levels in
response to H2O2 treatment
The MAPK subfamilies are activated in response to oxidant
injury, thus contributing to apoptosis onset following oxidative
insults. In order to evaluate the potential implication of MAPK sig-
naling pathway in the protective effect of OFE or Ole against H2O2-
induced apoptosis in HEK-293 cells, we assessed the expression of
Erk 1/2 and p38, two subfamilies of MAPK. Fig. 6A reveals that
H2O2 treatment (400 mMfor 30 min) increased the ratio phospho/to-
tal compared to untreated cells. In addition, the phosphorylated p38
was markedly increased in H2O2-treated cells above the basal level.
Interestingly, the pretreatment with OFE or Ole (200 and 50 mg/mL
for 24 h, respectively) induced a significant decrease in p38 and
Erk 1/2 phosphorylation (Fig. 6A) compared to H2O2-treated cells.
3.7. Involvement of Akt signaling in hydrogen peroxide-induced
damage
Akt, one of the major signaling enzymes involved in cell survival
against oxidative stress, is able to suppress apoptosis and promotecell survival. The influence of OFE and its phenolic component Ole
on H2O2-induced Akt dephosphorylation was determined using an
anti-phospho-Akt monoclonal antibody which detects phosphory-
lated Akt at Ser473. Hydrogen peroxide treatment (400 mM, 30
min) resulted in a marked decrease in Akt phosphorylation with
respect to untreated cells (Fig. 6A). However, pre-treatment with
OFE (200 mg/mL, 18 h) prior to hydrogen peroxide treatment pre-
vents the inhibition of Akt phosphorylation. Similar results were
observed with 50 mg/mL of Ole pre-treatment.3.8. OFE and Ole regulated the mRNA expression levels of apoptosis-
related factor
To confirm the action of OFE and Ole on the stress response
pathway, we analyzed the expression level of other members
known to be involved in apoptosis mediated by H2O2. In particular,
we analyzed the expression of Sirt 1 and Ask 1 by quantitative PCR
analysis.
Sirt 1, a member of the Sirtuin family, is known to control Bax-
mediated apoptosis through Ku70 (Cohen et al., 2004; Yeung et al.,
2004). Whereas, Ask 1 (apoptosis signal-regulating kinase 1)
encodes for a serine/threonine protein kinase ubiquitously
expressed, which activates MKK3/6-p38 signaling pathways. This
gene has been reported to be activated in response to H2O2
treatment.
Fig. 4. Flow cytometry analysis of apoptotic cells. Live cells (quadrant L), Mid and late apoptotic cells (quadrants MA and LA) and dead cells (quadrant D) detected by flow
cytometry after 6 h of exposure to H2O2 alone or cells pretreated for 18 h with OFE (100 and 200 mg/mL) or Ole (25 and 50 mg/mL) were analyzed. Ctrl: untreated cells. Results
were compared to control cells: * p < .01;** p < .001 and to cells treated with H2O2 alone: # p < .01; ## p < .001.
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these genes could be found in response to hydrogen peroxide treat-
ment. Our results indicated that OFE and Ole treatments were able
to rescue the up-regulation of Ask 1 and Sirt 1 mRNA levels
induced by H2O2 treatment (Fig. 7). Indeed, H2O2 treatment (400
mM, 30 min) significantly increased Sirt 1 and Ask 1 mRNA of about
2.5 and 2.97-fold, respectively compared to untreated cells. The
addition of OFE (200 mg/mL) or Ole (50 mg/mL) for 24 h significantly
reduced the mRNA levels of both genes.3.9. Protection against H2O2-induced inflammation through
modulating Cox-2 protein expression
Finally, we investigated whether the protective effect of OFE
and Ole could have potential anti-inflammatory activities by mod-
ulating Cyclooxygenase-2 (Cox-2) expression. Cox-2 is an impor-
tant enzyme that mediates inflammatory processes. The up-
regulation of Cox-2 has been associated with inflammatory disor-
ders (Surh et al., 2001).
As shown in Fig. 6B, the expression of Cox-2 protein signifi-
cantly increased in response to hydrogen peroxide treatment.Again, OFE (200 mg/mL) or Ole (50 mg/mL) pre-treatment for 24 h
induced a significant decrease of Cox-2 levels in HEK-293 cells
compared to those treated with H2O2 alone (400 mM, 30 min).4. Discussion
Recently, it has been reported that oxidants and oxidative mod-
ifications are among the main factors leading to cell and tissue
damage. Indeed, it has been shown that hydrogen peroxide con-
tributes to cellular damage in different cell lines (Choi, Cho, Seo,
Lee, & Park, 2016; Ding, Wang, Li, & Ma, 2016), and in particular
they cause renal cellular injury leading to nephrotoxicity
(Salahudeen, Clark, & Nath, 1991). Moreover, it is well known that
in kidney, oxidative stress can be increased by contrast media used
for radio diagnostic procedures, determining acute nephropathy.
Hence, Ole and OFE were selected for analyzing their abilities to
minimise H2O2-induced oxidative stress in HEK-293 cells.
In this study, we first analyzed the effects of various concentra-
tions of OFE (10, 50, 100, 200, 400 and 600 mg/mL) and Ole (0.5, 5,
25, 50, 100 and 200 mg/mL) on HEK-293 cell line proliferation (data
not shown). Interestingly, treatment for 24 h with increasing con-
Fig. 5. Effect of OFE and Ole on Bax/Bcl-2 ratio and p21 in H2O2-induced HEK-293 cells. Total protein from HEK-293 cells treated with OFE or Ole were used in western blot
analysis to detect the expression of Bax and Bcl-2. A: cells pretreated with OFE (200 mg/mL) or Ole (50 mg/mL) for 18 h prior to H2O2 treatment (6 h). B: cells pretreated with
OFE (200 mg/mL) or Ole (50 mg/mL) for 24 h prior to H2O2 treatment (30 min) to analyze the expression of p21. In all the experiments, b-actin was used as loading control. C
and D: Histograms of relative expression level refer to proteins normalized expression and derived by the analysis of three independent experiments. The values are
expressed as the mean ± SD. * indicates a significant difference compared with control cells (P < .05). # indicates a significant difference compared with the H2O2-treated cells
(P < .05).
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highest concentrations of OFE and Ole with no cytotoxic effect
were chosen to evaluate their ability to protect cells from hydrogen
peroxide-induced damage and apoptosis in HEK-293 cells.
Then, after using H2O2 to induce cell damage, we investigated
the protective effects of OFE, a Tunisian olive fruit extract, and its
phenolic compound oleuropein. The MTT assay showed that perox-
ide treatment caused loss of viability in HEK-293 cells compared to
untreated cells. These findings are similar to previous studies
reporting viability decrease both in human kidney cells (HEK-
293) (Liu et al., 2014) and in kidney tubule epithelial cells (NRK-
52E) (Wang, Matsushita, Araki, & Takeda, 2002) treated with H2O2.
It is well known that oxidative stress caused by hydrogen per-
oxide treatment enhances the oxidation of proteins and lipids
and causes DNA damage leading to cell death (Liu et al., 2014).
Moreover, Salahudeen et al. (1991) reported that H2O2 enhances
ROS levels through increasing intracellular calcium and that lipid
alterations contribute to H2O2-mediated renal cells injury.
In this study, we observed that HEK-293 cells exposed to H2O2
showed an increase of TBARS and ROS levels as well as the level of
apoptosis as evidenced by the increase of mid and late apoptotic
cell populations. On the contrary, the hydrogen peroxide effect
was strongly reverted in presence of OFE or Ole in a dose-
dependent manner.
In the same context, it has been reported thatmitochondrial dys-
function appears to initiate ROS production and lysosomal mem-
brane permeabilization, thus causing cell damage (Guicciardi,
Leist, & Gores, 2004). Different studies reported that H2O2-
mediatedmitochondrial dysfunctions and caspases activation leads
to endothelial cell apoptosis (Cai, 2005; Fen-fang et al., 2015).In an attempt to understand the molecular mechanism by
which H2O2 induces apoptosis, we examined the involvement of
caspases in the apoptotic process. OFE and Ole alleviated the apop-
tosis triggered by H2O2 indicating a protective role of both extracts
on renal cell lines. Bax protein is a member of the Bcl-2 family that
promotes apoptosis. Recently, it has been reported that Bax can
initiate apoptosis through its own activation. Indeed, Bax translo-
cates to the external mitochondrial membrane, rendering it perme-
able by oligomerizing and releasing some death-promoting factors
(Cohen et al., 2004).
Bcl-2 family members have been described also as key regula-
tors of mitochondrial permeability (Cory & Adams, 2002), and it
is known that the increase of Bax/Bcl-2 ratio determines the sus-
ceptibility of a cell to apoptosis. To understand the potential mod-
ulating effect of OFE and Ole on increased Bax/Bcl-2 ratio, we
analyzed the expression of both proteins by western blot. The
results showed that increased Bax/Bcl-2 ratio, following H2O2
treatment, was re-established when cells were pretreated by OFE
or Ole. In addition, we observed that OFE and Ole treatments mod-
ulate the over expression of p21. This protein, a cyclin-dependent
kinase inhibitor 1, is known to up-regulate Bax protein expression
and to antagonize the death-protective function of Bcl-2 in
response to cell damage (Kang, Kim, & Choi, 1999). These results
allowed us to suggest that p21 promotes H2O2-induced apoptosis
via enhancing the expression of Bax, thus modulating the molecu-
lar ratio of Bcl-2/Bax in HEK-293 cells.
MAPK (Mitogen-Activated Protein Kinases) play a significant
role in many biological processes, including cell adhesion, cell dif-
ferentiation and apoptosis. In particular, they are involved in coor-
dinating the response to ROS formation, thus influencing cell fate.
Fig. 6. Effect of OFE and Ole on phosphorylated Erk and p38 MAPK and Akt. An equal amount of total protein from untreated cells (Ctrl) or those treated with OFE (200 mg/mL)
or Ole (50 mg/mL) for 24 h prior to H2O2 treatment (30 min) were used in western blot analysis to analyze the expression of P-Erk, Erk, P-p38, P-Akt, Akt (A), and Cox-2 (B). b-
actin was used as loading control. (C) and (D) Histograms of relative expression level refer to proteins normalized expression and derived by the analysis of three independent
experiments. The values are expressed as the mean ± SD. * indicates a significant difference compared to control cells (P < .05). # indicates a significant difference compared to
H2O2-treated cells (P < .05).
Fig. 7. The Gene expression in HEK-293 cells. mRNA was extracted from cells treated with H2O2 (400 mM, 30 min) alone or following pre-treatment for 24 h with OFE (200 mg/
mL) or Ole (50 mg/mL) and analyzed by Real Time PCR. Sirt 1 (A) and Ask 1 (B) relative mRNA levels were normalized using GAPDH as housekeeping gene. Ctrl: control or
untreated cells. * p < .05; ** p < .01 compared to control cells. ### p < .001; ## p < .01; # p < .05 compared to H2O2-treated cells.
A. Maalej et al. / Journal of Functional Foods 39 (2017) 18–27 25The MAPK subfamilies ERK, JNK and p38 have been shown to be
activated in response to oxidant injury contributing to apoptosis
onset following oxidative insults (Fico et al., 2004).
In the present work, the expression of both Erk 1/2 and p38 was
analyzed. Our results showed that the protection mediated by OFE
and Ole could involve the MAPK signaling cascades. In fact, theinhibition of both kinases reduced apoptosis triggered by H2O2
treatment. These observations are in agreement with previous
studies showing that the ability to preserve cells from oxidative
damage, exerted by hydroxytyrosol in porcine renal epithelial cell
line (Incani et al., 2010), by hesperetin in fibroblasts (Pollard,
Whiteman, & Spencer, 2006) or also by quercetin to protect
26 A. Maalej et al. / Journal of Functional Foods 39 (2017) 18–27cardiomyoblasts (Angeloni, Spencer, Leoncini, Biagi, & Hrelia,
2007), is due to the Erk1/2 pathway activation.
Although Erk1/2 phosphorylation has been observed to be unaf-
fected in response to peroxide treatment in cardiomyoblasts
(Angeloni et al., 2007), its level was shown to increase in renal cells
(Zhuang & Schnellmann, 2006).
Activation of Akt, one of the major signaling enzymes involved
in cells survival against oxidative stress, has been shown to sup-
press apoptosis and promote cell survival (Kang et al., 2010). Addi-
tionally, it has been revealed that Akt is involved in cell death
regulation (Fresno Vara et al., 2004) through different cell survival
mechanisms or apoptosis, as reported in the renal cellular model
(Sinha, Bannergee, Schwartz, Lieberthal, & Levine, 2004). To ana-
lyze the mechanism of OFE and Ole mediated cell survival, we
examined the phosphorylation of Akt. Western blot analysis
showed that both OFE and Ole were able to prevent H2O2-
induced inhibition of Akt phosphorylation. These findings are in
agreement with studies performed in other cell lines such as por-
cine renal epithelial cells and cardiomyoblasts where hydroxyty-
rosol and quercetin, respectively, were able to modulate Akt
phosphorylation level (Angeloni et al., 2007; Incani et al., 2010).
The ability of olive compounds, OFE and Ole, the stress response
pathway, was further confirmed by the analysis of the expression
level of two genes involved in apoptosis mediated by H2O2. In par-
ticular, we analyzed the expression of Sirt 1 and Ask 1 by quantita-
tive PCR analysis. Sirt 1, a member of the Sirtuin family, is a
nicotinamide adenosine dinucleotide-dependent histone deacety-
lase, that was shown to control Bax-mediated apoptosis through
Ku70 (Cohen et al., 2004; Yeung et al., 2004). Besides, it has been
reported that ROS accumulation in response to H2O2 treatment
resulted in the activation of the apoptosis signal-regulating kinase
1 (Ask 1). This later encodes for a serine/threonine protein kinase
ubiquitously expressed, which activates MKK3/6-p38 signaling
pathways. Based on this data, the probable increase of Ask 1 mRNA
level in response to peroxide treatment to ROS accumulation was
checked.We observed that OFE andOle treatmentswere able to res-
cue the up-regulation of Sirt 1 andAsk 1 induced byH2O2 treatment.
This suggests that both OFE and Ole may inhibit Bax expression by
decreasing Sirt 1 expression in response to peroxide treatment.
Since inflammation is closely linked to oxidative damage, sub-
stances with strong anti-inflammatory activities are anticipated
to exert a protective effect on oxidative diseases. Cyclooxygenase-
2 (Cox-2) is an important enzyme that mediates inflammatory pro-
cesses. The up-regulation of Cox-2 has been associated with inflam-
matory disorders (Surh et al., 2001). In this study, we showed that
OFE and Ole exhibit similar significant protection against hydrogen
peroxide-induced cellular inflammation through inhibiting Cox-2
expression. The ability of OFE and Ole to modulate MAPK signaling
pathwaymight contribute to the inhibition of inflammation. In fact,
it has been reported that Erk 1/2 and p38 MAP Kinases are key ele-
ments of the intracellular signaling cascades leading to NF-jB acti-
vation, thus modulating Cox-2 expression (Surh et al., 2001). Our
findings well agree with previous studies reporting that quercetin
down regulated OTA-induced Cox-2 expression in HepG-2 cells
(Ramyaa, Krishnaswamy, & Padma, 2014) and that oleuropein pro-
tected mice kidneys from oxidative damage and apoptosis by mod-
ulating Jnk 1/2, Erk 1/2 and p38 MAPK, and from inflammation by
decreasing Cox-2 expression (Potocˇnjak, Škoda, Pernjak-Pugel,
Peršic´, & Domitrovic´, 2016).
The mode of action of OFE and Ole reported in this study is in
agreement with previous findings showing that the olive oil
polyphenols exhibit chemopreventive effects through p38/CREB
signaling pathway (Corona et al., 2007). Our results showed that
OFE and Ole have comparable effects.
In conclusion, our results suggest that OFE and Ole exhibit cyto-
protective effect in HEK-293 cells against H2O2-induced oxidativedamage and apoptosis. Furthermore, OFE and Ole-induced cell sur-
vival correlates with Akt activity, and the protection of kidney cells
against H2O2-induced apoptosis could be stimulated by the activa-
tion of p38 and Erk MAPK. The present results suggest that OFE and
Ole prevent oxidative stress-induced apoptosis via regulation of
PI3K/Akt and MAPK signaling pathways. All these data suggest that
OFE and Ole may be used in the treatment of kidney degenerative
diseases. However, further studies are needed to explore the
details of their protective pathway as well as their bioavailability
and metabolism in human kidney.
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Ultraviolet (UV) radiations are responsible for skin photoaging inducing alteration of themolecular and cellular pathways resulting
in dryness and reduction of skin elasticity. In this study, we investigated, in vitro, the antiaging and antioxidant effects of hyaluronan
formulations based hydrogel. Skinko` E, an intradermic formulation composed of hyaluronic acid (HA), minerals, amino acids, and
vitamins, was compared with the sole HA of the same size. For this purpose, HaCaT cells were subjected to UV-A radiations and
H
2
O
2
exposure and then treated with growth medium (CTR) combined with M-HA or Skinko` E to evaluate their protective ability
against stressful conditions. Cells reparation was evaluated using a scratch in vitro model and Time-Lapse Video Microscopy. A
significant protective effect for Skinko` Ewas shownwith respect toM-HA. In addition, Skinko` E increased cell reparation.Therefore,
NF-kB, SOD-2, and HO-1 were significantly reduced at the transcriptional and protein level. Interestingly, 𝛾-H2AX and protein
damage assay confirmed the protection by hyaluronans tested against oxidative stress. G6pdΔ ES cell line, highly susceptible to
oxidative stress, was used as a further cellular model to assess the antioxidant effect of Skinko` E. Western blotting analyses showed
that the treatment with this new formulation exerts marked antioxidant action in cells exposed to UV-A and H
2
O
2
. Thus, the
protective and reparative properties of Skinko` E make it an interesting tool to treat skin aging.
1. Introduction
Dermal exposure to UV is responsible for skin photoaging
[1]. Ultraviolet A (UV-A) represents 90% of all UV radiations
[2]. However, UV-B and UV-Amay challenge epidermal cells
(keratinocytes, melanocytes, Langerhans’, and Merkel’s cells)
possibly impairing the metabolism of these cells [3]. Besides,
UV-A photons tend to damage the skin even after a short
exposure [4], inducing the phosphorylation of JNK through
an increase of intracellular ROS in human keratinocytes
(HaCaT) [5]. Other manuscripts reported the impact of ROS
on keratinocytes, proving also in this cell model the specific
external stress, which can generate oxygen species in the cells
[6]. Also, extensive UV-A exposure to DNA damage similar
to UV-B exposure is reported by Mouret and collaborators
[7]. These radiations penetrated into the deep area of the
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dermis and destroyed the connective collagen and elastin
fibres in the tissue, challenging the cellular homeostasis. As
a result, the macromolecular assembly of collagen and elastin
in the skin may be impaired or modified, thus causing the
skin to become thinner and lose elasticity [8]. The process
leads to the catabolism of extracellular matrix components
(collagens and proteoglycans) with a loss of matrix [9]. This
phenomenon is particularly due tomatrixmetalloproteinases
expression. A strong degradation of type I collagen also
occurs in irradiated skin compared with nonirradiated skin
[10]. In addition, excessive exposure induces alteration of
the biomechanical properties of dermal connective tissue
resulting in dryness and reduced skin elasticity [11]. These
changes are coupled with DNA damage induced by reactive-
oxygen species (ROS) production [12] that not only lead to
premature aging of the skin but also increase the risk of
contracting skin cancer. Moreover, ROS, inducing apoptosis,
reduces the number of skin fibroblasts and decreases their
regenerative capacity, leading to increased skin sagging [13].
Furthermore, environmental pollutants may contribute to
prompt symptoms of extrinsic skin aging, including coarse
wrinkles, irregular pigment spots, and elastosis [14]. Thus,
the identification of new compounds, which are effective in
protecting skin cells, is an important tool to prevent and/or
to contrast the damage induced by ultraviolet radiation.
Currently, there is a great tendency to use different skin
care product formulations, considering their effect on the
reduction of free radicals production generated from ultra-
violet radiation. To date, stimulation of skin biorejuvenation
is facilitated by minimally invasive intradermal injections
of biologically active substances [15, 16] such as hyaluronic
acid- (HA-) based gels and dermal fillers [17] alone or in
combination with other molecules [18, 19]. Reports show that
HA accelerates in vitro processes related to wound healing
[20] and in vivo tissue regeneration, increasing the produc-
tion of extracellular matrix components [21] that reduce the
signs of aging [22]. In particular, HA enhances hydration
in the extracellular space due to its ability to attract water
molecules [23] and induces optimal physiological conditions
in the extracellular matrix for cell proliferation [24] and
the organization of fibroblasts. Recently, the protective effect
of HA has been proposed as an effective tool against skin
damage [25]. An intradermic formulation containing linear
HA and antioxidants, which is able to suppress oxidative
stress-induced apoptosis in skin fibroblasts, can be a potential
treatment for maintaining healthy youthful skin. In the
present study, we evaluated the hydrodynamic and biological
characterization of a compound containing linear HA plus
a mixture of vitamins, antioxidants, and minerals named
VISCODERM Skinko` E [14]. The aim of this work was
to understand the mechanism of the action of medium
molecular weight HA (M-HA) and the same HA added with
vitamins, antioxidants, and minerals on in vitro models of
oxidative damage.
2. Materials and Methods
2.1. Materials. TheM-HA was obtained in our laboratory by
heterogeneous hydrolysis acid ofHA 1200 kDa pharma grade,
kindly provided by Altergon s.r.l., following the procedure
reported in D’Agostino and collaborators (2017) [25]. In
particular, size-exclusion chromatography, equipped with
a triple detector, permitted the following characterization:
500±80 kDa, Mw/Mn=1,6. Intrinsic Viscosity=1,1±0,2 m3/kg
[25]. The compound was then dissolved in phosphate-
buffered saline (PBS) (6,4 mg/ml in PBS) and microfiltered
(0,22 𝜇m) in order to be sterilized. Endotoxin content
was lower than 0,05 EU/mg. Skinko` E (6,4 mg/mL) was
kindly provided by IBSA Farmaceutici Lodi-Italia. This
intradermic formulation was released by dissolving HA raw
material with an intrinsic viscosity ranging from 0,90 to
1,34 m3/kg. Composition for 5 mL vial, as reported in
the commercial leaflet contains, apart from the linear M-
HA, biotechnological origin. Buffered preservation media
contain (1) inorganic salts: Ammonium molybdate, ammo-
niummetavanadate, calciumchloride, iron sulfate, potassium
chloride, copper sulfate, magnesium chloride, manganese
sulfate, sodium acetate, sodium hydrogen carbonate, sodium
chloride, sodium hydrogen phosphate, sodium metasilicate,
sodium selenite, tin chloride, and zinc sulfate; amino acids:
alanine, arginine, asparagine, aspartic acid, cysteine, glu-
tamine, glutamic acid, glycine, histidine, isoleucine, leucine,
lysine, methionine, phenylalanine, proline, serine, threonine,
tryptophan, tyrosine, valine, and adenine; vitamins: biotin
(vitamin H), calcium pantothenate (vitamin B5), choline
chloride, folic acid (vitamin B9), inositol, nicotinamide,
pyridoxine (vitamin B6), riboflavin (vitamin B2), thiamine
(vitamin B1), cyanocobalamin (vitamin B12); antioxidants:
lipoic acid; others: inositol, glucose, putrescine, and sodium
pyruvate. MHA and Skinko` E were opportunely diluted 1:1
with complete growth medium, supplemented with fetal
bovine serum (FBS) to obtain 1% v/v FBS for the time-
lapse experiment. For all experiments, Skinko` E and M-
HA solutions were diluted 1:2 from stock solutions of 0,64%
w/w in cell medium and then used at a 0,32% v/v final
concentration.
2.2. Cell Culture. The immortalized human keratinocyte cell
line (HaCaT) was obtained from Istituto Zooprofilattico,
(Brescia, Italy). Cells weremaintained at 37∘C in a humidified
atmosphere containing CO
2
(5% v/v) in Dulbecco’s mod-
ified Eagle’s medium supplemented with 10% fetal bovine
serum, 2mM glutamine, and 1% penicillin/streptomycin. For
the experiments, HaCaT cells were incubated with freshly
prepared dilutions of the M-HA 0,32% w/v and Skinko` E
0,32% w/v, and in growth medium, for the specified time and
concentration range.
A mouse embryonic stem (ES) cell line, which was
engineered through the deletion of the glucose-6-phosphate-
dehydrogenase gene (G6pdΔ cells) [26] and the wild type
(WT) ES cell, was maintained in an undifferentiated state
by culture on a monolayer of mitomycin C inactivated
fibroblasts, in the presence of leukemia-inhibiting factor
(LIF) [27]. Cells were seeded, at equal density on gelatin-
coated plates, 48 hours before treatment. Cells were treated
with 100 mU/ml (WT ES) or 10 mU/ml mU (G6pdΔ ES) of
glucose oxidase (GOX; Sigma-Aldrich) for 30 minutes and
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Table 1: Primer sequences used for the qRT-PCR.
Gene Forward Primer Reverse Primer AT PCR
HPRT 5’-TGACCTTGATTTATTTTGCATACC-3’ 5’-CGAGCAAGACGTTCAGTCCT-3’ 55∘C
SOD-2 5’-CTGGACAAACCTCAGCCCTA-3’ 5’-TGATGG CTTCCAGCAACTC-3’ 55∘C
HO-1 5’- GCAGTCAGGCAGAGGGTGATAGAAG-3’ 5’- TGGTCCTTGGTGTCATGGGTCAG -3’ 55∘C
then incubated in the presence of M-HA or Skinko` E and
harvested after 8 hours.
2.3. Sample Preparation. VISCODERM Skinko` E formula-
tion was concentrated on a polyethylene sulfate membrane
with a nominal molecular weight limit (NMWL) of 3 kDa
(Amicon Ultra 0.5 mL Centrifugal filter: Ultracel 3 kDa, Mil-
lipore). The concentration was diafiltered using 2 volumes of
HPW (High Purified Water). Successively, the ultrafiltration
(UF) retentate on the 3 kDa centricon tube was recovered
and eventually diluted for the hydrodynamic characterization
by SEC-TDA; whereas, the permeate 3 kDa was analyzed
by uronic acid assay (E.P. ed 5.0: 2.2.25). This last assay
quantified the residual HA in the permeate and diafiltered
sample that accounted for about the 25% w/w of the initial
HA amount. Therefore, the permeate 3 kDa contained all
the Skinko` E components and a residual 1,84 mg/mL of HA.
This was diluted 1:2, tested as for Skinko` E, and thus, the
final concentration of HA in the cell’s plate was 3,2 mg/mL
for the complete formulation and only 0,92 mg/mL for the
permeation. In this case, theHAeffect should be reducedwith
respect to the other compounds present in the formulation.
2.4. Hydrodynamic Characterization SEC-TDA. The chro-
matographic analyses of ultra-filtered retentate Skinko` E
and M-HA using size-exclusion chromatography coupled
with triple detection array (SEC-TDA by Viscotek Malvern
Instruments, UK) were performed. The details of the system
and the analytical conditions have been reported by La
Gatta et al. (2010) [28]. The molecular size, molecular weight
distribution, polydispersity, and the intrinsic viscosity of the
samples have been derived for a complete hydrodynamic
characterization.
2.5. Wound Healing In Vitro Model on HaCaT. The in
vitro scratch assay procedure has been fully previously
described [18, 20]. In brief, 12 wells (precoated with collagen)
were seeded with HaCaT (1,5×103cells/cm2) and incubated
for 48 hours until complete confluence was reached, in
order to test the effect of M-HA and Skinko` E (0,32%
w/v), respectively, on the rate of wound closure, monitored
by Time-Lapse Videomicroscopy (TLVM). Fresh serum-
supplementedmediumwith 1% v/v FBSwas used as a control.
The images of the scratched monolayers were captured every
60 minutes and analyzed using OKO Vision 4.3 software
(Okolab, Italy) [25].
2.6. Analysis of SOD-2 andHO-1 through qRT-PCR. To test in
vitro antioxidant activity, HaCaT cells were treated with M-
HA and Skinko` E for 4 hours, with and without preexposure
to U-VA radiation (𝜆max 365 nm) for 4 minutes [29]. For
the analysis of gene expression, total RNA was extracted,
using Trizol, according to the manufacturer’s procedures
(Invitrogen, Milan, Italy). Retrotranscription was performed
using Reverse Transcription System Kit (Promega, Milan,
Italy). PCR was then performed using iQ SYBR1-Green
Supermix (Bio-Rad Laboratories s.r.l., Milan, Italy) to ana-
lyze the expression levels of superoxide dismutase-2 (SOD-
2), heme oxygenase 1 (HO-1), and hypoxanthine guanine
phosphoribosyl transferase (HPRT), using the specific primer
pairs designed with Beacon Designer software (Bio-Rad
Laboratories s.r.l., Milan, Italy). Primer sequences have been
reported in Table 1 and the amplification conditions have
been fully described in Stellavato and collaborators (2016)
[30]. All PCR reactions were performed in triplicate and
the relative expression of specific mRNA with respect to the
hypoxanthine guanine phosphoribosyl transferase (HPRT)
housekeeping gene. The comparative threshold method
2−ΔΔCt (ΔΔCt = difference of ΔCt between HA treated cells
and control) has been used to calculate the fold-change of
genes and the results have been expressed as normalized fold
expression, compared with controls using the Bio-Rad iQ5
software (Bio-Rad Laboratories s.r.l.).
2.7. Western Blotting for NF-kB and HO-1 as Inflammatory
Markers. For the evaluation of western blotting, HaCaT cells
were treated with M-HA and Skinko` E for 24 h with and
without preexposure to U-VA radiation (𝜆max 365 nm) for
4 minutes [29]. The proteins were extracted using a RIPA
lysis buffer and the concentrations were determined using
the Bio-Rad protein assay reagent (Bio-Rad Laboratories,
Milan Italy). Equal amounts of proteins (30 𝜇g) were loaded
on a SDS-PAGE and transferred them to a nitrocellulose
membrane [31]. The filters were incubated with antibodies
against the nuclear factor kappa-light-chain-enhancer of
activated B cells (NF-kB; rabbit polyclonal IgG C-20; 1:200
v/v ), heme oxygenase 1 (HO-1; goat polyclonal IgG C-18;
1:200 v/v), and actin (actin; goat polyclonal IgG I-19; 1:500) at
room temperature for 2 hours.Membraneswerewashed three
times for 10 minutes and incubated with a 1:5000 dilution
of horseradish peroxidase-conjugated anti-rabbit antibod-
ies and with a 1:10000 dilution of horseradish peroxidase-
conjugated anti-goat antibodies for 1 hour, respectively. All
antibodies are purchased from Santa Cruz Biotechnology,
CA,USA. Blots were developed using the ECL system accord-
ing to themanufacturer’s protocols (Amersham Biosciences).
Extracted proteins from Skinko` E treated WT and G6pdΔ
ES cells [32] and untreated cells were analyzed using PARP
antibody (New England Biolabs.). Actin antibody was used
as the gel loading control. The same procedure of western
blotting was followed to analyze 𝛾-H2AX (primary antibody
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Figure 1: Hydrodynamic characterization by SEC-TDA is reported for (a) Skinko` E UF retentate and (b) M-HA.
anti-𝛾H2AX: Cat No. 05-636 from Millipore, MA, USA) as
specific biomarker of DNA damage prompted by oxidative
stress.
2.8. Antioxidant In Vitro Activity Using T-Bars Assay
on HaCaT. Reactive aldehydes were assessed by measur-
ing thiobarbituric acid-reactive substances (TBARS), as
described previously [32]. The effect of Skinko` E on HaCaT
cells (2,0 x105) was tested in four different experimental
setups:
(1) To test the effect on the poststress process, the cells
were pretreated for 30 minutes with 50 𝜇MH
2
O
2
and
then incubated with M-HA and Skinko` E (0,32% v/v)
for 24 hours.
(2) To test the antioxidant activity, M-HA and Skinko` E
were applied simultaneously with 50 𝜇M H
2
O
2
(30
min) or exposed to a U-VA radiation (𝜆max 365 nm)
for 4 minutes.
(3) To test the effect of the permeate (3 kDa) Skinko`
E formulation, with respect to complete Skinko` E
formulation on HaCaT cells, the cells were pretreated
with 50 𝜇M H
2
O
2
or exposed to a U-VA radiation
(𝜆max 365 nm).
The protein concentrations were determined using the Bio-
Rad protein assay reagent (Bio-Rad Laboratories, Milan
Italy). A TBARs assay (thiobarbituric acid-reactive sub-
stances) was performed on aliquots of membranes which
were extracted (10 𝜇l) and added to 2 ml of TBA-TCA (TCA
15% w/v, TBA 0,3% w/v in HCl 0,12 N) solution at 100∘C for
30 minutes. The chromogen, produced by the stoichiometric
reaction of aldehydes (malondialdehyde (MDA)) with thio-
barbituric acid (TBA), was quantified by spectrophotometric
reading at a wavelength of 532 nm. The amount of TBARs
was expressed as a percentage of lipid peroxidation and then
normalized with respect to the control.
3. Results
3.1. Molecular Weight, Polydispersity, and Intrinsic Viscosity
Determination by SEC-TDA. The Skinko` E product (Visco-
derm Skinko` E VEVU04), analyzed by SEC-TDA, contains
HA with an intrinsic viscosity of 0,97±0,2 m3/kg, which is
within the expected range (as reported by the producer). A
comparative analysis of Skinko` E and M-HA (produced by
our laboratory) showed similarities to the chromatographic
profile (see Figures 1(a)-1(b)) and derived analytical software
parameters. Detailed analyses ofmolecular distribution high-
lighted a molecular weight fraction above 700 kDa of 14%,
whereas over 40% resulted above 400 kDa for both Skinko`
E andM-HA.These results confirmed comparable molecular
weight distributions between samples, thus permitting a cor-
rect biological/cellular comparison between the treatments.
3.2. In vitro Scratch Assay Using Time-Lapse VideoMicroscopy
(TVLM). Wound healing experiments showed that the
scratch closure occurred at a faster rate in the presence
of Skinko` E and M-HA (the control cells being in normal
medium). Between the two M-HA based samples analysed,
the Skinko` E acted faster thanM-HA. In particular, in wound
closure, the soleM-HAachieved 70%of reparation at 14 hours
compared with 18 hours for the control. Surprisingly, a higher
performance was found for Skinko` E. In fact, samples treated
with Skinko` E reached the same repair target (70%) within
9 hours (see Figure 2), corresponding to a 2-fold increase
of the reparation rate with respect to the control and also a
significant 30% improvement with respect to the sole M-HA.
3.3. Gene andProtein ExpressionAnalyses. M-HAand Skinko`
E showed the capability of preventing UV-A stress, in vitro, in
experiments accomplished using a model recently described
by Almeida and collaborators (2015) [25]. SOD-2 and HO-
1 were markedly reduced at the transcriptional level. In
particular, SOD-2 and HO-1 gene expression, as reported in
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Figure 2: (a) Representative micrograph pictures of HaCaT scratch assays. (b) Repair area percentage for the control and in the presence of
treatments: M-HA and Skinko` E; the curves are averages of three different experiments with standard deviation within 5% of the value. (c)
Rate of reparation within 96 hours. Skinko` E and M-HA treatments are statistically significant ∗(p<0.05) with respect to CTR, Skinko` E and
M-HA treatments are statistically significant ∗∗(p<0.01) with respect to CTR, and Skinko` E is statistically significant §(p<0.05) with respect
to M-HA treatment.
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Figure 3: Antioxidant biomarkers (SOD-2 and HO-1) were deter-
mined by quantitative real-time PCR on HaCaT UV-A pretreated
for 4 minutes and subsequently treated withM-HA 0.32% (w/v) and
Skinko` E 0.32% (v/v) for 4 hours. Each column represents the mean
and error bars represent the standard deviation (n=3). Test-t was
performed to evaluate the significance ofM-HAand Skinko` E effects
with respect to positive control (UV-A), ∗p<0.01.
Figure 3, were significantly downregulated with respect to
UV-A treatment in the presence of Skinko` E. SOD-2 was
reduced 2,4-fold, and HO-1 2-fold, with respect to M-HA
alone. Similarly, the protein levels of NF-kB and HO-1 (see
Figures 4(a)-4(b)) significantly decreased in the presence of
M-HA and Skinko` E. Both the treatments were effective but
Skinko` E reduced NF-kB and HO-1 expression 3,3-fold and
2,6-fold, respectively, compared with M-HA alone (the data
are statistically significant).
3.4. Oxidative Protein Damage. As further biomarker of
the oxidative stress we evaluated the protein expression of
the 𝛾-H2AX (primary antibody anti-𝛾H2AX: Cat No. 05-
636 from Millipore, MA, USA), through western blotting
analysis following the procedure described in the previous
section. The quantification of carbonyl groups introduced
into proteins by oxidative reactions was detected by OxyBlot
kit (data not shown). Densitometric analysis of 𝛾-H2AX
(Supplementary File (available here)) showed that M-HA
and Skinko` E reduced the protein expression with respect to
oxidative stress induced. In particular, both the treatments
were effective, but Skinko` E reduced 𝛾-H2AX expression 1,7-
fold and 1.3-foldwith respect toH
2
O
2
andUV-A, respectively,
compared with M-HA that reduced it 1.5 and 1.1 with respect
to both oxidative stresses induced.
3.5. TBARS Assay. To assess the antioxidant activity, in
vitro tests were conducted on M-HA and Skinko` E. Human
keratinocytes were treated with oxygen peroxide or exposed
to UV-A radiation, and TBARS assay (see Figure 5) showed
that the levels of lipid peroxidation dramatically increased
in response to both H
2
O
2
and UV-A exposure, whereas M-
HA 0,32% w/v reduced the amount of lipid peroxidation. To
better unravel the functionality of the diverse components,
Skinko` E was subjected to UF treatment on the 3 kDa
membrane and both retentate and permeation were tested
separately. Retentate contained over 70% of the total HA
present, while permeation clearly contained vitamins and
components at low molecular weight and a residual HA that
proved randomly able to permeate for about 25-30% of total
amount contained in the formulation. This particular behav-
ior is known to occur in linear polyanionic polysaccharides
that assume specific enlarged conformations in solution, in
order to reduce the repulsion forces in between the dimeric
repetitive units.When the cells were exposed, simultaneously,
to M-HA, Skinko` E and Skinko` E permeate (3 kDa) in
the presence of H
2
O
2
or U-VA, respectively (see Figures
6(a)-6(b)), the levels of lipid peroxidation were substantially
reducedwith respect to relative positive control. In particular,
Skinko` E and Skinko` E permeation significantly reduced lipid
peroxidation 1,3- and 1,5-fold with respect to M-HA alone in
HaCaT exposed to UV-A (see Figure 6(b)).
3.6. Skinko` E Protection against Oxidative Stress-Induced
Apoptosis. To further investigate the protection mechanism
of Skinko` E treatments against oxidative stress-induced apop-
tosis, we used a mouse embryonic stem cell line (ES) [33].
In particular, we used an ES cell line which was extremely
sensitive to oxidative stress (G6pdΔ ES cells). G6pdΔ is an
engineered ES cell line carrying the deletion of the glucose-
6-phosphate-dehydrogenase gene. Indeed, G6PD is essential
for the production of high levels of NADPH required for
the cell detoxification of reactive-oxygen species [22]. We
focused on H
2
O
2
as the oxidant, WT ES, and G6pdΔ ES
cells were treated, respectively, with 100mU/ml or 10mU/ml
of glucose oxidase (GOX), an enzyme that produces H
2
O
2
in
the cell culturemedium, from glucose andwater. As shown in
Figure 7, Skinko` E, but notM-HA, reverted the effect of GOX,
protecting bothWTES andG6pdΔES cells against apoptosis.
Since Skinko`E protected both WT and G6PD delta from
H
2
O
2
induced apoptosis, we can speculate that molecules
present in the formulation can act as antioxidants, bypassing
the function normally performed by NADPH.
Statistical Analysis. All the data are represented as the mean
± SD.When there was no variability in the values for a group,
a one-sample t-test was used to compare the group mean to
that value; otherwise a two-sample t-test was used to compare
group means. p< 0.05 was considered significant in each of
the comparative analyses.
4. Discussion
The present experimental study provided consistent infor-
mation regarding biochemical changes in cells after in vitro
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Figure 4: Western blotting analyses showed that M-HA and Skinko` E reduce the inflammatory proteins NF-kB and HO-1. In particular,
Skinko` E is more efficient than M-HA on these protein modulations.
Figure 5: Effect of M-HA 0.32% (w/v) and Skinko` E 0.32% (v/v)
on lipid peroxidation after exposure to oxidative stress induced
by 50𝜇M H
2
O
2
for 30 minutes. M-HA and Skinko` E treatments
are statistically significant (∗p<0.01) comparing with the positive
control (H
2
O
2
). Also, Skinko` E is statistically significant (∗p<0.01)
with respect to M-HA treatment.
oxidative damage. This included the potential protective
effects, such as, antioxidant activity, not only of M-HA,
but also of a formulation based on M-HA plus minerals,
amino acids, and vitamins. Due to its rich formulation, the
injectable solution of hyaluronic acid, complemented with
these small molecules (Skinko` E), demonstrated its efficacy
against oxidative stress, which is considered the main cause
of skin aging or photoaging. To our knowledge, oxidative
damage in terms of H
2
O
2
in vitro treatment [32] and UV-A
irradiation [33] also contribute to this detrimental condition.
To better evaluate the effect of Skinko` E formulation, with
respect to the sole M-HA, HaCaT cells were used as the in
vitro cellular model. Normally, in the skin, oxidative stress
is due to reactive-oxygen species (ROS) that can originate
both from exogenous factors (i.e., the environment) and
from endogenous factors [34, 35]. Specifically in vitro tests
were carried out to assess the antioxidant activity on M-
HA and Skinko` E. Human keratinocytes were treated with
oxygen peroxide or exposed to UV-A radiation, showing
an increased lipid peroxidation; the latter was significantly
reduced by treating the cells with both M-HA and Skinko` E.
Interestingly, the beneficial effect was also found when the
HaCaT cells were treated with the Skinko` E UF permeation
(3 kDa) that consisted of the low molecular weight fraction
(vitamins, antioxidants, amino acids, and minerals) [14] and
a small amount of residual HA (0,92 mg/ml). In addition,
in vitro wound healing experiments showed that Skinko` E
was superior to the sole HA of the same MW in promoting
wound closure, with a relevant and significant improvement
that showed in triplicate experiments to accomplish 70%
repair in half the time. Beside the UV-A stress in vitromodel
was here tested as discussed by Almeida [29]. Interestingly,
this was also prevented by both M-HA and Skinko` E with
a marked improvement for the latter that reduced, at tran-
scriptional level, both SOD-2 and HO-1 and protein level
NF-kB and HO-1. Since these biomarkers are relevant in
assessing the state of the cells, our aim was to highlight the
efficacy of the formulations used against the two different
oxidative stress insulting conditions tested in this research
work. In this respect, our results relative to the decrease of
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Figure 6: Effect of M-HA 0.32% (w/v), Skinko` E 0.32% (v/v), and permeate (3KDa) Skinko` E on lipid peroxidation after exposure to
oxidative stress induced by 50𝜇M H
2
O
2
(a) or UV-A irradiation (b) on HaCaT cells. “∗” in the histogram indicates significant difference
at p<0.01, comparing with the Skinko` E and UF Skinko` E Permeate 3kDa treatment groups with respect toM-HA. Data of the amount of lipid
peroxides (% respect to CTR) are reported as follows: Graph (a): H
2
O
2
=570±14, M-HA=128±7.0, Skinko` E=95.5±7.7, UF Skinko` E Permeate
3kDa=109±4.2. Graph (b): UV-A=480±14.0, M-HA=114±7.0, Skinko` E=74±5.6, UF Skinko` E Permeate 3kDa=76±7.0.
Figure 7: Protective effect of Skinko` E against oxidative stress-induced apoptosis.
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protein biomarkers of oxidative stress (e.g., SOD-2) could be
explained through the hypothesis that antioxidants enzymes
are activated late following the oxidative stressUV-A induced.
In our opinion, the cells survived to the treatment with H
2
O
2
produced SOD-2 as protective enzyme. While in presence
of hyaluronans, the cells do not need to activate it, because
specifically both M-HA and Skinko` E are able to counteract
ROS production, thus reducing the overall stress that the cells
experience. Our observations were supported by the work
of Leccia and collaborators [36]. Specifically, they reported
that antioxidant enzymes are activated relatively late after
the initial UV damage and hence could be considered as
“late-response” genes and proteins. However, the oxidative
protein damagewas evaluated supporting a lower detrimental
action when cells were exposed to (treated with) M-HA and
Skinko` E. In addition, the western blot analyses with 𝛾-
H2AX further support a lower damage to both H
2
O
2
and
UV-A induced stress when the cells received contemporary
the treatments. Specifically Skinko` E was permitted to lower
damage [37, 38]. The present study confirmed that the use
of the intradermal HA solution with other active ingredients
may increase keratinocytes function. In particular, amino
acids and vitamins present in the Skinko` E formulation are
important nutrients to maintain youthful epidermal appear-
ance. For instance, the vitamin B complex is reported to act
as free radical scavengers. Also biotin and inositol, important
intracellular messengers, play a key role in the synthesis
of the matrix proteins forming the cellular scaffolds/ tissue
architecture [36]. In addition, antioxidants properties could
be also related to the presence of lipoic acid in the formulation
tested. The latter, in fact, has been studied for its benefits
to skin as potent natural antioxidant [39]. Specifically, lipoic
acid improved clinical characteristics related to photoaging
of facial skin [40] and also is able to act as protective agent
against UV-B induced damage [41]. In vitro studies showed
its action as ROS scavenger may be accomplished through
the direct suppression of the UVR-induced NF-kB activation
in human immortalized keratinocytes [42]. In order to test
the ability of Skinko` E and M-HA to prevent apoptosis,
G6PD delta ES was chosen as cellular model system since
they are extremely sensitive to oxidative stress [26]. We
have previously demonstrated that it is a reliable model
system to analyze apoptosis. Moreover, all the procedures to
analyze oxidative stress-induced apoptosis in ES cells have
already been set up and described [33]. Using G6pdΔ ES
cells, we showed that Skinko` E is also able to protect cells
against oxidative induced apoptosis through the produc-
tion of NADPH, that is, a central enzyme in cell defense
against redox insults. Indeed, in order to reduce H
2
O
2
, both
essential enzymes, glutathione reductase and catalase, require
NADPH; the first enzyme requires NADPH as a cofactor to
reduceGSSG inGSH, and the second to formactive tetramers
out of a single enzymatically inactive subunit. Looking at the
Skinko` E formulation, we observed that the three constitutive
amino acids of the tripeptide GSH were present in the mix.
We can speculate that the presence of these amino acids
could induce de novoGSH synthesis, supplying cells with new
reducing power essential to counteract the oxidative damage.
Amino acids and vitamins are also important ingredients
for maintaining a youthful appearance. As reported by Tosti
[43], the vitamin B complex is essential in different metabolic
functions, also acting as free radical scavengers. In addition,
the oxidative stress and more generally, the ROS production
are among the recognized mechanisms affecting melanocyte
disorders which alter skin pigmentation. In particular, Wan
and collaborators [44] reported thatmelanocytes protect skin
cells against UV radiation through melanin biosynthesis.
Continuous UV radiation exposes melanocytes to oxida-
tive stress and, in this condition, exposed epidermal cells
gradually lose this function, resulting in anomalous pigment
production [45].
5. Conclusions
The present research work suggests a potential role of the
Skinko` E formulation on dermal dark spot treatment, in
relation to its activity against oxidative stress. Overall the
results of this research work confirmed the effectiveness of
Skinko` E and of M-HA on cell repair and regeneration
through increased cell proliferation and the migration capac-
ity of keratinocytes. It is well known that increased ROS,
altering apoptotic pathways, can foster the development of
dermatological diseases and aging.Therefore Skinko` E, which
protects cells against ROS-induced apoptosis, can play a role
in maintaining healthy youthful skin, preventing or delaying
skin aging and eventually the onset of skin diseases.
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